Presentations and Lectures

Invited Presentations and Lectures

(Title, Inviting Institution/Group or Individual; Location, Date)

  1. “Conditions of the Oral Cavity of Importance to Internists”, Dr. Beck, University Hospital; January 8, 1980.
  2. “A Diagnostic Approach to Oral Lesions”, Dr. M. Natrass, Regina Dental Society; Regina, Saskatchewan, February 11, 1980.
  3. “Oral Manifestations of Connective Tissue Diseases”, Dr. Javier, Department of Medicine, University Hospital, March 3, 1980.
  4. “Oral Diagnosis/Oral Medicine”, Dr. D. Campbell, Dental Program, Department of Northern  Saskatchewan, Sturdy Stone Building; Saskatoon, Saskatchewan, March 26, 1980.
  5. “Oral Candidiasis:  Problem Oriented Record System”, Dr. S. Nakao, Josai Dental University; Josai, Japan, June 9, 1980.
  6. “Oral Candidiasis:  Microbial Adherence in Mucosal Disease”, Dr. J. Philip Sapp, UCLA; Los  Angeles, California, July 7, 1980.
  7. “Problem Oriented Record System”, Diagnostic Sciences Study Club; Saskatoon, Saskatchewan, November 29, 1980.
  8. “Procedures of Head and Neck, Examinations”, Diagnostic Sciences Study Club; Saskatoon, Saskatchewan, November 29, 1980.
  9. “Oral Manifestations of Infections, Trauma and Tumors”, Ms. Sheena Blackwell, Saskatchewan  Dental Nurses & Assistants Association; Saskatoon, Saskatchewan, February 10, 1981.
  10. “Problem Oriented Dental Record System”, Dr. John Eisner, Dalhousie University;  Halifax, Nova Scotia, February 12, 1981.
  11. “Oral Lesions in Family Practice”, Dr. M. Rostoker, Family Practice Seminar, Department of  Family Medicine, City Hospital; Saskatoon, Saskatchewan, March 4 & 11, 1981.
  12. “Chronic Pain and Multidisciplinary Pain Clinics”, Dr. C. Greene, TMJ and Facial Pain Research Center, University of Illinois; Chicago, Illinois, March 16, 1981.
  13. “Problem Oriented Approach in Dental Treatment:  Use of Bone Scintigraphy in Management of Patients with TMJ Disease”, Dr. J. Plecash, Dr. C. Baker, Faculty of Dentistry, University of Alberta; Edmonton, Alberta, March 25, 1981.
  14. “Principles of Patient Examination:  Common Problems of Oral Medicine in Children and Adolescents”, Ms. Juanita Delschneider, Saskatchewan Dental Nurses Association Convention; Regina, Saskatchewan, May 8, 1981.
  15. “Acute/Chronic Pain”, Dr. J. Wilson, Saskatoon & District Dental Society; Saskatoon, Saskatchewan, May 12, 1981.
  16. “Oral Pathology/Oral Medicine in Family Practice”, Dr. P. Lane, in Dermatology in Family Practice, Continuing Medical Education, University of Saskatchewan, May 28-30, 1981.
  17. “Treatment Planning”, Dr. Ron Gier, Organization of Teachers of Oral Diagnosis Workshop; St. Petersburg, Florida, June 7-11, 1981.
  18. “Soft Tissue Diseases of the Oral Cavity”, Dr. Dunn, Family Practice Seminar, Department of Family Medicine, City Hospital, Saskatoon, Saskatchewan, September 8, 1981.
  19. “Role of the Dentist in Patients with Leukemia”, Dr. D. Johnson, Dental Department, St. Paul’s Hospital; Saskatoon, Saskatchewan, October 6, 1981.
  20. “Recognition and Diagnosis of Oral Soft Tissue Disease and Oral Cancer”, Drs. J. Epstein and T. Morton, College of Dental Surgeons of Saskatchewan; Regina, Saskatchewan, October 17- 18, 1981.
  21. “Oral Medicine – Diagnosis, Patient Exam, Chronic Pain”, Dr. M. Riviera, Prince George District Dental Society; Prince George, BC, January 17, 1982.
  22. “Chronic Facial Pain and Multidisciplinary Pain Clinics”, Dr. C. Gregory, Columbia Centre for Pain & Stress Management; Vancouver, BC, February 3, 1982.
  23. “Oral Soft tissue Disease and Oral Cancer”, Dr. J. Davis, Upper Island Dental Society; Nanaimo, BC, February 13, 1982.
  24. “Oral Ulcerations” in Oral Medicine 412, Dr. B. Blasberg, Department of Oral Medicine, University of BC; Vancouver, BC, February 10 & 17, 1982.
  25. “Dental Pain” in Pain and Pain Management.  The 1982 Symposium on Professional Psychology, University Hospital, University of Saskatchewan; March 5-6, 1982.
  26. “Hepatitis B and the Dental Profession”, The Canadian Association for Clinical Microbiology and Infectious Disease, Symposium on Hepatitis B; Montreal, Quebec, April 19-20, 1982.
  27. “Facial Pain”, Dr. J. Girard, one day seminar in conjunction with Dr. B. Blasberg, Victoria & District Dental Society; Victoria, BC, April 22, 1982.
  28. “Debugging Your Dental Office”, Standards of Dental Office Sterilization, Panel Discussion, Drs. J. Epstein, Dr. J. Main, Dr. A. Parnell, Dr. A. Sussel, CDA/ODA Convention; Toronto, Ontario, May 11, 1982.
  29. “Hepatitis B and the Dental Profession – Hepatitis B Testing”, Canadian Red Cross Blood Transfusion Service, Dr. J. Epstein, CDA/ODA Convention; Toronto, Ontario, May 9-12, 1982.
  30. “Dental Management of the Medically Compromised Patient”, Dr. B. Blasberg, Continuing Dental Education, University of BC; Vancouver, BC, October, 1982.
  31. “Practical Management of Oral Mucosal Disease”, Dr. Len Atkinson, Victoria & District Dental Society, Oak Bay Beach Hotel; Victoria, BC, October 4, 1982.
  32. “Clinical Pathological Conference”, Dr. Bob Priddy, Western Teachers of Oral Pathology (Westop) Meeting, University of BC; Vancouver, BC, October 15, 1982.
  33. “Intracapsular TMJ Disorders”, Dr. B. Blasberg, Oral Medicine IV, University of BC; Vancouver, BC, November 26, 1982.
  34. “A Clinical Trial of Mouthwetting Agents”, Table Clinic, Vancouver & District Dental Society; December 3, 1982.
  35. “Common Oral Soft Tissue Lesions”, Dr. J. Sandbrand, Alpha Omega Dental Fraternity, Vancouver, BC, December 7, 1982.
  36. “Dental Management in Hospitalized Patients Including Radiation and Cancer Chemotherapy Patients”, Ms. Linda Burgess, F6, Shaughnessy Hospital; Vancouver, BC, January 10, 1983.
  37. “Acute/Chronic Pain”, Dr. P. Nelson, Oral & Maxillofacial Surgeons of BC, Faculty Club, University of BC; Vancouver, BC, January 12, 1983.
  38. “Cancer and the Dentist – Effects of Current Cancer Therapy on the Mouth, Mouth Care for Cancer Patients”, Dr. Ian Thompson, American Cancer Society of Bellingham MidWinter Meeting, Mount Baker Dental Society; Bellingham, Washington, February 18, 1983.
  39. “Oral Lesions – Diagnosis and Management”, Dr. C. Stelmaschuk, Fraser Valley Dental Society; Abbotsford, BC, February 23, 1983.
  40. “Hepatitis B Vaccine – Should We Vaccinate”, Dr. P. Trester, Vancouver & District Dental Society; Vancouver, BC, March 8, 1983.
  41. “Protocol for Management of Oral Problems of Hematology Patients”, Dr. G. Growe, Acting Head, Department of Hematology, Vancouver General Hospital; Vancouver, BC, March 18, 1983.
  42. “Oral Cancer, Diagnosis, Characteristics”, Dr. B. Blasberg, Oral Medicine III, University of BC; Vancouver, BC, March 23, 1983.
  43. “Oral Stomatitis”, Dr. T. Sparling, Resident Staff, Shaughnessy Hospital; Vancouver, BC, March 31, 1983.
  44. “Clinical Pathological Conference”, Dr. B. Goldstein, American Academy of Oral Medicine Meeting, Hyatt Regency Hotel; Vancouver, BC, April 28, 1983.
  45. “Oral Medicine – Patient Evaluation and Treatment Planning”, Dr. K. Buschel, Thompson- Okanagan Dental Society; Kelowna, BC, May 7, 1983.
  46. “Recognition & Management of Oral Mucosa in Radiotherapy and Chemotherapy for Home Nursing”, Mrs. M. Fletcherberg, Ms. S. Hughes, Boundary Health Unit, Home Nursing Care Program; Surrey, BC, June 8, 1983.
  47. “Diagnosis and Management of Oral Soft Tissue Diseases”, Drs. J. Peraya and V. Lepp, Northwestern, BC Dental Society; Terrace, BC, June 25-26, 1983.
  48. “The Role of Dentistry in Patients with Malignant Disease”, Drs. G. Catton and J. Hardie, Ontario Cancer Foundation, Ottawa Clinic, Ottawa Civic Hospital; Ottawa, Ontario, September 15, 1983.
  49. “Hepatitis B and the Dentist, the Staff and the Family”, in Panel – Infection and Disease Control, Canadian Dental Association Convention; Vancouver, BC, September 26, 1983.
  50. “Management of the Immunocompromised Patient”, Oral Cancer and the Dental Practitioner, Panel Moderator, and Presentation, Canadian Dental Association Convention; Vancouver, BC, September 28, 1983.
  51. “Clinical Trial of Mouthwetting Agents”, Drs. J. Epstein, P. Stevenson-Moore and Ms. Anne Caird, Canadian Dental Association Convention; Vancouver, BC, September 28, 1983.
  52. “Management of Xerostomia – Caries Control”, Drs. P. Stevenson-Moore, J. Epstein, J. Krasse and Ms. Anne Caird, Canadian Dental Association Convention; Vancouver, BC, September 28, 1983.
  53. “Hepatitis B and Dentistry”, Dr. F. Turner, Fraser Valley & District Dental Society; Abbotsford, BC, November 9, 1983.
  54. “Oral Cancer:  Diagnosis and the Role of Dentistry”, Dr. J. Little, University of Minnesota; Minneapolis, Minnesota, November 16, 1983.
  55. “Hepatitis – The Virus, the Disease and Prevention”, Dr. B. Sammons and Mr. M. Lipscomb(MSD), Oak Bay Beach Hotel; Victoria, BC, November 21, 1983.
  56. “Orofacial Pain in Cancer Patients”, Dr. F. Howell, Department of Oral Medicine and Stomatology, Scripps Clinic and Research Foundation; La Jolla, California, January 5, 1984.
  57. “Internal Derangement of the TMJ”, with Dr. G. Wittenberg, Vancouver & District Dental Society; Vancouver, BC, January 17, 1984.
  58. “Facial and TMJ Pain”, with Dr. B. Blasberg; Yale Malkin, Van-Bel Study Club; Vancouver, BC, March 14, 1984.
  59. “Complications Associated with the Treatment of Malignant Lesions”, Dean K. Bentley, Dr. E. Miller, McGill University, Faculty of Dentistry, fourth year students, Montreal General Hospital;  Montreal, Quebec, April 6, 1984.
  60. “Oral Cancer Pain – A Focused Look”, Western USA Pain Society Annual Meeting; Santa Barbara, California, May 16-19, 1984.
  61. “Hepatitis B and Dentistry”, Drs. Smith and Ross, Merck-Frosst Canada; Vancouver, BC, June 28, 1984.
  62. “Oral Cancer”, Dr. Dana Otterhold, Mount Baker & District Dental Society; Bellingham, Washington, September 11, 1984.
  63. “The Electronic TMJ”, Orthodontics 84 Study Club, Dr. C. Wishart; Vancouver, BC, October 15, 1984.
  64. “Cancer Chemotherapy”, In:  Management of the Patient at Medical Risk, sponsored by the Organization of Teachers of Oral Diagnosis, at the American Dental Association 125th Annual Session; Atlanta, Georgia, October 21, 1984.
  65. “Pain Control for Head and Neck Cancer Patients”, American Academy of Oral Medicine, mid-annual meeting, World Trade Center; New York, New York, December 11, 1984.
  66. “Cancer Chemotherapy, A New Challenge for Dentistry”, Vancouver and District Dental Society, MidWinter Clinic; Vancouver, BC December 7, 1984.
  67. “Infection and Infection Control in Dental Practice”, Dr. J. Epstein (course co-ordinator), with Drs. R. Mathias, B. McBride and W. Sussel, Continuing Dental Education, University of BC; Vancouver, BC, January 19, 1985.
  68. “Orofacial Pain in Cancer Patients”, Dr. A. Ross, College of Dentistry, University of Saskatchewan; Saskatoon, Saskatchewan, February 11, 1985.
  69. “Hepatitis B, The Risks, Prevention of Infection”, Greater Vancouver Dental Hygienist Society; Vancouver, BC, February 27, 1985.
  70. “Antibiotic Prophylaxis of Bacterial Endocarditis”, Vancouver & District Dental Society, General Meeting, Hyatt Regency; Vancouver, BC, March 5, 1985.
  71. “Management of Xerostomia:  Control of Dental Caries”, Alpha Omega Dental Fraternity, Denman Place Inn, Vancouver, BC, March 12, 1985.
  72. “Cancer Chemotherapy”, Annual Founders Day Program, Organization of Teachers of Oral Diagnosis; Las Vegas, Nevada, March 16, 1985.
  73. “Pain Control”, Meeting of BC Oncology Nurses Interest Group, Ethical Dilemmas in the Care of the Person with Cancer, A Challenge for Nurses; Richmond, BC, April 13, 1985.
  74. “Update and New Developments in Hepatitis”, Graduating Dental Students, sponsored by  Merck-Frosst, Canada, Faculty Club, University of BC; Vancouver, BC, April 17, 1985.
  75. “Prophylaxis of Bacterial Endocarditis”, Department of Dentistry Quarterly Meeting, Children’s Hospital; Vancouver, BC, April 18, 1985.
  76. “Prospective Double Blind Clinical Trial of a Topical Anaesthetic in Management of Pain in Oropharyngeal Mucositis”, Western USA Pain Society, Annual Meeting; Incline Village, Nevada, May 9, 1985.
  77. “Facial Pain in Cancer Patients”, Nassau County Medical Center, Department of Dentistry; Long Island, New York, May 21, 1985.
  78. “Dental Concerns – AIDS and Hepatitis B from a Dental Prospective”, in Health and Safety Issues of AIDS & Hepatitis B for Health Care Staff, BC Health Association, Branch of the Canadian Public Health Association, University of BC; Vancouver, BC September 14, 1985.
  79. “The Oral Complications of Cancer Chemotherapy and Radiotherapy” and Chairman, Symposium on Oral Cancer, Canadian Dental Association Annual Convention; Ottawa, Ontario, October 2, 1985.
  80. “Infectious Disease in Dental Practice:  AIDS, Herpes & Hepatitis”, with Dr. R. Mathias; Dr. K. Doyle, Upper Island Dental Society; Nanaimo, BC, October 26, 1985.
  81. “Infectious Disease in Dental Practice:  AIDS, Herpes and Hepatitis”, with Dr. R. Mathias; Dr. B. Legatto, Thompson-Okanagan Dental Society; Kelowna, BC, November 4, 1985.
  82. “Infection Control:  Update on AIDS and Hepatitis B”, Vancouver Dental Assistants Association; Vancouver, BC, November 20, 1985.
  83. “Hepatitis B:  Risk and Prevention Among the Dental Community”, Manitoba Dental Association, Merck, Sharp & Dohme; Winnipeg, Manitoba, November 26, 1985.
  84. “Watch Out for AIDS”, Vancouver & District Dental Association, MidWinter Clinic, Hotel Vancouver; Vancouver, BC, November 29, 1985.
  85. “Infection Control”, Dr. B. Legatto, Thompson-Okanagan Dental Society; Kelowna, BC, January 17, 1986.
  86. “Infection Control”, Dr. John Fraser, Victoria & District Dental Society; Victoria, BC, January 24, 1986.
  87. “The Dentist’s Role in Oncology”, Dr. Dave Waterbury, Oral Diagnosis Study Club; Vancouver, BC, January 27, 1986.
  88. “AIDS, Hepatitis and Patient Contact”, A Practical Course for Dentists, Dental Assistants and  Hygienists, with Dr. R. Mathias, Calgary Convention Centre; Calgary, Alberta, February 8, 1986.
  89. “New Developments in Hepatitis”, Senior Dental Class, University of BC, Merck-Frosst; Vancouver, BC, February 13, 1986.
  90. “Infectious Disease in Dental Practice:  AIDS, Herpes & Hepatitis”, with Dr. R. Mathias, Prince George Dental Society; Prince George, BC, March 2, 1986.
  91. “Infectious Disease in Dental Practice:  AIDS, Herpes & Hepatitis”, with Dr. R. Mathias, College of Dental Surgeons of BC Annual Meeting, Hotel Vancouver; Vancouver, BC, March 5, 1986.
  92. “Infectious Disease in Dental Practice:  AIDS, Herpes & Hepatitis”, with Dr. R. Mathias, Kootenay Dental Society; Cranbrook, BC, March 21, 1986.
  93. “A Symposium on Infectious Disease in Dental Practice:  AIDS, Herpes and Hepatitis B”, Drs. J. Epstein (co-ordinator), R. Mathias, S. Silverman, K. Gelmon, R. Thordarsen, Continuing Dental Education, University of BC; Vancouver, BC, April 12-13, 1986.
  94. “Infectious Disease in Dental Practice:  AIDS, Herpes & Hepatitis B”, with Dr. R. Mathias, College of Dental Surgeons of Saskatchewan; Saskatoon, Saskatchewan, April 19, 1986.
  95. “AIDS, Herpes & Hepatitis B Awareness”, Fraser Valley Certified Dental Assistants Society;  Cloverdale, BC, April 24, 1986.
  96. “A Prospective Double Blind Trial of a Topical Anaesthetic in Management of Pain in Oropharyngeal Radiation Mucositis”, American Academy of Oral Pathology Annual Meeting; Toronto, Ontario, May 13, 1986.
  97. “Management of Radiation Mucositis”, Clinical Investigations and Patient Care Branch, National Institute of Dental Research, National Institute of Health; Bethesda, Maryland, May 14, 1986.
  98. “Public and Emergency Services, AIDS Vancouver Networking Conference, Workshop leader; Vancouver, BC, May 31, 1986.
  99. “Oral Management of the Radiation Patient”, Society for Oral Oncology Annual Meeting/American Cancer Society Annual Cancer Conference, Workshop leader, Red Lion Inn; Bellevue, Washington, June 21, 1986.
  100. “Oral Complications in Leukemia”, in Leukemia-Oncology Seminars, St. Francis Medical Center, Education Department; Honolulu, Hawaii, November 14, 1986.
  101. “Update on Oral Care of Cancer Patients”, Tumor Conference, St. Francis Medical Center; Honolulu, Hawaii, November 17, 1986.
  102. “Diagnosis & Treatment”, in The Management of Dysfunctional Disorders of the Temporomandibular Joints.  Continuing Dental Education, University of BC and Interspecialty Dental Society of BC; Vancouver, BC, January 31, 1987.
  103. “AIDS Update”, Joint Hospital Education Committee, Medical Staff St. Joseph & St. Luke’s Hospital; Bellingham, Washington, February 24, 1987.
  104. “Oral Cancer/Leukemia”, Dental Hygiene Students, Vancouver Vocational Institute; Vancouver, BC, March 2, 1987.
  105. “Orofacial Pain & TMJ Pain”, Dr. P. Barer, Orthodontics 84 Study Club; Vancouver, BC, March 30, 1987.
  106. “Facial Pain Syndromes”, BC Endodontic Society, April 6, 1987.
  107. “Oral Complications of Bone Marrow Transplantation”, Children’s Hospital, Department of Dentistry; Vancouver, BC, April 16, 1987.
  108. “AIDS”, Community Council, St. Joseph’s Hospital; Bellingham, Washington, April 22, 1987.
  109. “Xerostomia and Other Oral Manifestations of Connective Tissue Disorders”, American Academy of Oral Medicine, Annual Meeting; Bal Harbour, Florida, May 7, 1987.
  110. “AIDS:  The Infectious Disease”, British Columbia Dental Hygienists Association, University of Golf Club; Vancouver, BC, May 24, 1987.
  111. “Saliva and Salivary Gland Dysfunction”, Society of Oral Oncology, Annual Meeting; Kansas City, Missouri, June 18, 1987.
  112. “A Review of Infectious Disease Significant to Dental Treatment in Management of the Infectious Dental Patient – Participation Clinic”, UBC and The College of Dental Surgeons of BC, Annual Meeting; June 21, 1987.
  113. “Infection & Infection Control”, Dental Public Health, Annual Meeting, Preventive Services, Ministry of Health; Victoria, BC June 25, 1987.
  114. “Dental Management in Stomatitis”, in “Stomatitis, Defining Effective Nursing Interventions”.  Workshop, Western Canadian Consortium for Cancer Nursing Research; Vancouver, BC, September 2-3, 1987.
  115. “Saliva:  Management of Xerostomia”, Department of Dental Medicine, Alberta Einstein Medical Center; Philadelphia, Pennsylvania, September 28, 1987.
  116. “AIDS, Hepatitis and Infectious Disease in Dentistry”, Victoria & District Dental Society; Victoria, BC, October 5, 1987.
  117. “AIDS and Your Dental Team”, with Dr. R.G. Mathias, Toronto Convention Centre; Toronto, Ontario, October 16, 1987.
  118. “Oral Manifestations of HIV Infection”, International AIDS Symposium, Conference on AIDS; Vancouver, BC, November 1-3, 1987.
  119. “Reducing the Fear of AIDS”, St. Luke’s Hospital, Focus on Health, 1987-1988; Bellingham, Washington, January 20, 1988.
  120. “Say AHHH – Disorders of the Mouth”, 23rd Annual Post Graduate Review in Family Medicine; Vancouver, BC, March 9, 1988.
  121. “AIDS:  The Changing Epidemic”, with Drs. S. Silverman, R. Mathias, J. Dillon, University of BC; Vancouver, BC, April 9, 1988.
  122. “Benzydamine Hydrochloride in Prevention of Oropharyngeal Mucositis in Radiation Therapy”, in “A Meeting on Benzydamine:  A Topical NSAID”; Stratford Upon Avon, United  Kingdom, April 22, 1988.
  123. “Dry Mouth”, with Dr. M. Schubert, Sjogren’s Support Group; Bellingham, Washington,  August 6, 1988.
  124. “Infectious Disease in 1988”, in:  A Bite of Law (II); College of Dental Surgeons of BC – Symposium; Richmond, BC, September 17, 1988.
  125. “The ABC’s of AIDS and Infection Control”, with Dr. R. Mathias, College of Dental Surgeons of Saskatchewan; Regina, Saskatchewan, September 24, 1988.
  126. “The ABC’s of Infectious Disease and Infection Control”, The Governing Board of Denture Therapists; Toronto, Ontario, October 22, 1988.
  127. “The ABC’s of AIDS and Infection Control”, with Dr. R. Mathias, Waterloo-Wellington Dental Society; Kitchener, Ontario, October 29, 1988.
  128. “Oral Medicine/Infectious Disease”, MidWinter Clinic, Vancouver & District Dental Society; Vancouver, BC, December 2, 1988.
  129. “AIDS – What Do I Need to Know?”, Vancouver Rotary Sunrise Club; Vancouver, BC, January 4, 1989.
  130. “Oral Care:  Clinical & Home Care”, in “Regional Symposium on AIDS”, Bellingham-Watcom County Department of Public Health; Bellingham, Washington, February 25, 1989.
  131. “Infectious Disease and Infection Control”, North West British Columbia Dental Society; Smithers, BC, March 12, 1989.
  132. “Infection Prevention in Bone Marrow Transplantation and Radiation Patients”, in “Oral Complications of Cancer Therapies:  Diagnosis, Prevention and Treatment”, NIH Consensus Development Conference; Bethesda, Maryland, April 17, 1989.
  133. “Oral Care:  Clinical and Homecare”, in “Second Regional Symposium on AIDS”; Bellingham, Washington, May 13, 1989.
  134. “Oral Kaposi’s Sarcoma in AIDS:  Management With Intralesional Chemotherapy”, in 5th International Conference on AIDS; Montreal, Quebec, June 5, 1989.
  135. “HIV Disease and AIDS:  The Role of the Dental Team in Management of the Oral Conditions”, at Canadian Dental Association Annual Convention; Vancouver, BC, August  28, 1989.
  136. “Periodontal and Gingival Involvement in Medically Compromised Patients”, at Canadian Dental Association Annual Convention; Vancouver, BC, August 30, 1989.
  137. “Government Rules and Regulations and Orthodontic Practice:  A Look in the Crystal Ball”, at Ortho 81 Study Club; Vancouver, BC, October 2, 1989.
  138. “Infection Control; Disposal of Dental Office Waste”, at Van-Bel Orthodontic Study Club; Vancouver, BC, October 18, 1989.
  139. “Hazards in the Dental Office”, Epstein JB (co-ordinator) with Nicholls J, Riben P. At Continuing Dental Education, University of BC; Vancouver, BC, October 21, 1989.
  140. “Changing Patters and Treatment of Oral Soft Tissue Lesions”, Mt. Baker District Dental Society; Bellingham, Washington, November 14, 1989.
  141. “New Rules and Regulations in Dental Practice”, Greater Vancouver Study Club; Vancouver, BC, November 15, 1989.
  142. “Treatment of Kaposi’s Sarcoma”, at Western Sectional Meeting, International Association of Dental Research; Vancouver, BC, November 18, 1989.
  143. “Orthodontics:  Infection & Infection Control”, Drs. Wainwright /Barer/Sproule /Metzner Orthodontic Groups, Arbutus Club; Vancouver, BC, January 8, 1990.
  144. “The AIDS Experience to 1990”, Dental Hygiene, Vancouver Vocational Institute; Vancouver, BC, January 23, 1990.
  145. “Oral Candidiasis in:  Treating Fungal Disease in a Hospital Setting”, University of British Columbia; Vancouver, BC, February 26, 27, 1990.
  146. “Office Hazards – Infection, Chemicals and Waste Disposal”, Whistler Seminars; Whistler BC, March 10, 1990.
  147. “Infection Control”, Vancouver Vocational Institute, Continuing Education; Vancouver, BC, March 26, 1990.
  148. “Management of oral complications caused by radiotherapy”, Tenth Annual Cancer Conference for The Dental Professional American Cancer Soc., Bellevue, Washington, June 8, 1990.
  149. “Risk of Infection in Patient Care”, American Anaplastology Association Fifth Annual Meeting, Seattle, Washington, June 9, 1990.
  150. “Strategies for the Management of Pain in Cancer Patients”.  Society for Oral Oncology/Fifth Annual Meeting; Orlando, Florida, June 29, 1990.
  151. “Hazards in the Dental Office; Kootney Dental Society, Annual Fairmont Hot Springs Seminar:  Fairmont Hot Springs, BC  September 22, 1990.
  152. Neoplasms in:  “The Provision of Oral Health Care for Patients with HIV Disease.”  Health &  Welfare Canada, Ministry of Health of Ontario, Medical Research Council and University of Western Ontario, London, Ontario, October 11-12, 1990.
  153. “Malignant Disease of the Head and Neck in HIV Infection” in:  Oral Problems of patients with AIDS and HIV infection.  Prince Hotel, Toronto, Ontario, October 13, 1990.
  154. “How to Survive Envirophobia in the Dental Office”.  Vancouver and District Dental Society  mid Winter Clinic, Vancouver, BC  November 23, 1990.
  155. “Management of Oropharyngeal Fungal Infections:  Department of Oral & Maxillofacial Surgery & Pathology.  Free University, ACTA, Amsterdam, Netherlands, November 27, 1990.
  156. “Oral Infections by Herpes Viruses.  Rijks Universiteit, Groningen, Netherlands, November 28, 1990.
  157. “Oral Complications of Radiotherapy in Oncologiedag, 1990:  Prevention and management of oral complications of oncology patients, Deventer, Netherlands, November 28, 1990.
  158. “Oral Candidosis”.  Bristol Dental Hospital, Bristol, United Kingdom, December 11, 1990.
  159. “Selected topics in Oral Cancer”.  Bristol Dental Hospital, Bristol, United Kingdom, December 13, 1990.
  160. Grand Rounds, Dept. of Medicine, St. Paul’s Hospital with Dean Paul Robertson, Vancouver, BC.  January 29, 1991.
  161. “Dental Interfaces with Sino Nasal Disease”.  Otolaryngology Resident Lecture Series, University of British Columbia, February 22, 1991.
  162. “Management of Oral Pain and Bleeding” in New Frontiers on Head and Neck Cancer, 7th   Annual Head and Neck Conference, American Cancer Society San Diego, California, March 1, 1991.
  163. “Office Hazards:  Infectious Disease, Waste Disposal” Annual Full Day Program, Upper Island  Dental Hygiene Society; Nanaimo, BC, March 9, 1991.
  164. “Oral Medicine in Oncology” BC Dental Meeting 1991; Vancouver, BC, March 16, 1991
  165. “Oral Medicine, Oral Manifestations of Systemic Disease with Dr. M. Williams, Annual Convention Denture Society of BC; Victoria, BC, April 13, 1991.
  166. Epidemiology with Dr. R. Mathias in “The Impact of HIV and other Infectious Agents on Oral Health Care, Canadian Dental Association; Ottawa, Canada, April 14 & 15, 1991.
  167. AIDS:  Professional Risk and Recognition of Oral Manifestations, Reach Dental Clinic; Vancouver, BC, April 30, 1991.
  168. “Clinical Management of Oral Pain.”  Sixth Annual Meeting, Society for Oral Oncology; Keystone, Colorado.  August  2, 1991.
  169. “Graft Versus Host Disease” with Dr. M. Schubert.  Sixth Annual Meeting, Society for Oral Oncology; Keystone, Colorado.  August 2, 1991.
  170. “Drug Management and Therapeutic Modalities in Sjogren’s Syndrome:  An Update on Etiology, Diagnosis and Management”,  Sponsors: Sjogren’s Syndrome Foundation, Swedish Hospital Medical Centre, Continuing Dental Education, Washington State Chapter Arthritis Foundation from a Swedish Hospital Medical Centre, Seattle, Washington.  October 19, 1991.
  171. “Oral Manifestations of HIV Disease”, Medical Residents’ Seminar Series, St. Paul’s Hospital, Vancouver, BC.  October 25, 1991.
  172. “Oral Care for Patients with HIV Disease:  An Update, Course Co-ordinator and Presentation of Recognition and Management of Oral Soft Tissue Disease in HIV and Head, Neck and Oral Malignancies in HIV and AIDS”, Continuing Dental Education, University of British Columbia, Vancouver, BC,  October 26, 1991.
  173. “Treatment of Oral Kaposi’s Sarcoma”,Third International Symposium on Oral AIDS, New York, NY, November 23, 1991.
  174. “Oral Manifestations of HIV”, City Wide Monthly Interdisciplinary AIDS Care Rounds, St. Paul’s Hospital, Vancouver, BC, January 16, 1992.
  175. Infection:  “Epidemics & Plagues”, Ortho Study Club 81.  Vancouver, BC, January 20, 1992.
  176. “Special Dental and Oral Needs Care of the AIDS Patient and Medically Compromised in a Hospital Setting; Update of Current Issues in Virology as Potential Hazards to Health Care Professionals”,  Vancouver Community College, Dental Hygiene Department, February 10, 1992.
  177. “AIDS: Infection Transmission to Patients”, Alpha Omega Whistler Ski Seminar, Delta Mountain Inn, Whistler, BC, February 22, 1992.
  178. “Oral Medicine: Oral Mucosal Disease Recognition, Diagnosis and Management”, Victoria and District Dental Society, Victoria, BC, April 4, 1992.
  179. “ABC of AIDS and Infection Control”, Kamloops Dental Society, Kamloops, BC, April 25, 1992.
  180. “Local Management of Post Radiation Changes”, American Academy of Oral Medicine Annual Meeting,  San Diego, CA, April 30, 1992.
  181. “Health Hazards/Health Promotion in Dentistry”, Workers Compensation Board, Forum on Occupational Safety and Health, Vancouver, BC, May 7, 1992.
  182. “Management of Oral Complications”, with Dr. P. Stevenson-Moore, Pharmacy Symposium, British Columbia Cancer Agency, Communities Oncology Program, Vancouver, BC, May 8, 1992.
  183. “Compliance Mechanisms”, Panel at:  Meeting on Blood Borne Pathogens in the Health Care Setting.  Health and Welfare Canada, Ottawa, Canada, May 15, 1992.
  184. “HIV and Dentistry in the Fraser Valley”, HIV/AIDS Conference, Langley Memorial Hospital, Langley, BC, May 23, 1992.
  185. “Detection of early dysplastic and malignant changes of the oral mucosa and their treatment” and “Diagnosis and treatment of tumors and malignancy of lesions of the oral cavity in AIDS patients” in:  Twelfth Annual Cancer Conference for the Dental Profession, American Cancer Society, Washington Division; Bellevue, Washington, May 29, 1992.
  186. “Topical cyclosporine for treatment of chronic oral graft vs. host disease” in:  Annual Meeting, International Society of Oral Oncology, San Diego, California, August 8, 1992.
  187. “Dental Handpiece Controversy”.  Thursday evenings lecture series for Dental Hygienists, continuing
    dental education; UBC with Dr. R. Mathias.  September 24, 1992.
  188. “Dental Care and HIV:  Are You at Risk?” with Dr. L. Magne.  AIDS Awareness Week, AIDS Vancouver and College of Dental Surgeons of BC.  Oct 5, 1992.
  189. “Infectious Disease/Infection Control” with Dr. R. Mathias.  Upper Island Dental Soc., Nanaimo, BC,
    Oct 24, 1992.
  190. “Recognition of The Manifestations in HIV/AIDS”, Mount Baker Dental Hygiene Society, Bellingham, Washington, January 14, 1993.
  191. Oral Manifestations of HIV infection in “The 3rd Symposium on the clinical aspects of HIV infection.”  Hospital St. Luc, Montreal, Quebec.  January 28 – 29, 1993.
  192. “Thirsty? – Management of Xerostomia and Oral Complications of Xerostomia.”  “Viruses we encounter.”  Alpha Omega Whistler Ski Seminar.  Whistler, BC.  February 20, 1993.
  193. “Infectious Diseases in Dental Practice in the 90’s.”  Annual Meeting British College of Dental Surgeons of British Columbia.  March 5 – 6, 1993.
  194. “Infectious Disease/Infection Control in a Changing World” with Mathias R, Molinari J, Blatherwick J.,  Continuing Dental Education,  University of British Columbia, Vancouver, BC,  March 27, 1993.
  195. “NIH recommendations in head and neck irradiated patients 1989-1993.  In Management protocols for oral sequelae of cancer therapy:  application of protocols in the individual patient”,  International Society for Oral Oncology, 8th Annual Meeting, Amsterdam, The Netherlands, April 24, 1993.
  196. “Infectious Disease – Infection Control” with Mathias, R.,   Dental Specialist Society of British Columbia,  Vancouver, BC,  May 21, 1993.
  197. “Risks and Practical concerns in Infection Control in Dentistry”,  Dental Staff Meeting, Children Hospital,  Vancouver, BC,  June 17, 1993.
  198. “Oral Care and Oral Medicine in the Age of AIDS”, College of Dental Surgeons of Saskatchewan Annual Scientific Session and University of Saskatchewan College of Dentistry 25th Anniversary Reunion,  Saskatoon, SK,  June 25, 1993.
  199. “The Practical Approach to the Management of Oral Complications of Cancer Therapies” with Schubert M., 13th Annual Cancer Conference for the Dental Profession, American Cancer Society, Washington Division, Bothell, WA, October 1, 1993.
  200. “Oral Management of Acute Complications of Cancer Therapy in Oral Cancer:  Your Professional Responsibility”,  Continuing Dental Education, University of British Columbia, Vancouver, BC, October 2, 1993.
  201. “Topical treatment for pre-malignant and early malignant lesions of the oral cavity”, Otolaryngology Grand Rounds, Faculty of Medicine, University of British Columbia, December 6, 1993.
  202. “Phantom Tooth Pain”,  BC Endodontic Society, Vancouver, BC,  February 23, 1994.
  203. “HIV Aids Treatment” with Washington P, Turner F, Hoek M.  In Legal Issues in Dental Practice in 1990’s.  University of British Columbia, Vancouver, BC,  March 3, 1994.
  204. “Infectious Disease and Infection Control:  Approaching the Year 2000”, College of Dental Surgeons of Saskatchewan, Regina, SK, March 23, 1994.
  205. “Oral Neoplasia and Oral Infection:  Diagnosis and Oral Care in Immunosuppressed and Non-Immunosuppressed Patients”,  Ontario Dental Association,  Annual Spring Meeting 1994, Toronto, ON,  April 23, 1994.
  206. “Management of Acute Mucosal Reaction in Dental Management of the Irradiated Patient”, 1st International Congress on Maxillofacial Prosthetics, Indian Wells, CA,  April 30, 1994.
  207. “Gingival and Periodontal Diseases”,  Mount Baker Dental Hygienist’s Association, Bellingham, WA,  May 19, 1994.
  208. “Clinical Trial of Bethanechol in Treatment of Xerostomia” with Burchill JL, Emerton S, Le ND, Silverman SJR.,  International Society for Oral Oncology,  Bethesda, MA,  June 3, 1994.
  209. “A Combined Analysis of a Toothbrush, Foam Brush and a Chlorhexidine Soaked Foam Brush in Maintaining Oral Hygiene”,  Int. Soc. for Oral Oncol.,  Bethesda, MA, June 3, 1994.
  210. “Emerging Issues in Infectious Diseases:  TB and Hepatitis C.” with Mathias R., Continuing Dental Education, UBC,  Vancouver, October 13, 1994.
  211. “The Management of Oral Cancer patients in Symposium on Current Concepts in the Diagnosis and Treatment of Mucous Membrane Diseases”, Federation Dentaire International/Canadian Dental Association Congress, Vancouver, BC, October 5, 1994.
  212. “Atypical Facial Pain in Orofacial pain:  Management of Difficult Facial Pain Problems”, Federation Dentaire International/Canadian Dental Association Congress,  Vancouver, BC, October 6, 1994.
  213. “Oral Manifestations in HIV Disease”,  8th Annual British Columbia HIV/AIDS Conference, HIV in Canada Today – Focus on Youth,  Vancouver, BC, November 6, 1994.
  214. “Cancer and the Role of the Dental Hygienist”, Coquitlam Periodontal Study Club, Coquitlam, January 11, 1995.
  215. “Emerging issues in infectious diseases for certified dental assistants – TB and hepatitis C” with Riben P, Mathias R., Continuing Dental Education, University of British Columbia, Vancouver, BC, January 25, 1995.
  216. “Are any of your patients HIV positive?  Are you positive….or could you tell?”  Mount Baker Dental Society and North Counties HIV/AIDS Care Consortium, Bellingham, WA,  March 22, 1995.
  217. “Compliance with use of fluoride carriers in Head and Neck Cancer Patients Treated with Radiation Therapy”, American Academy of Oral Medicine annual meeting,  Nashville, TN,  May 3, 1995
  218. “Diagnosis and Management of Orofacial Pain in The Scope of Oral Medicine” with Drs. Blasberg, Goldstein, Ho, Van, and Williams,  Dental Specialists Society, Annual General Meeting, Vancouver, BC, May 12, 1995.
  219. “HIV and the Mouth”,  British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, May 18, 1995.
  220. “Temporomandibular disorders following motor vehicle accidents. In: Litigating Traumatic Brain injury cases: Identification, evaluation and presentation of the evidence”, Trial Lawyers Association of British Columbia, Vancouver, BC, May 20, 1995.
  221. “The Dental Handpiece Controversy”, with Lauriente D., Continuing Dental Education, University of British Columbia, Vancouver, BC, January 25 and February 7, 1996.
  222. “Diagnosis and Treatment of Cancer Associated Pain”,  American Academy of Oral Medicine, 50th Annual Meeting, San Diego, CA, May 3, 1996
  223. “Oral Neoplasms: Kaposi’s Sarcoma and Lymphomas”, Third International Workshop on the Oral Manifestations of HIV Infection, London, England, May 30, 1996.
  224. “Quality of Oral Function Following Radiation Therapy”, International Society for Oral Oncology, 11th Annual Meeting, Stockholm, Sweden,  June 14th, 1996.
  225. “Oral Examination Practice Sessions and Identification of Oral lesions of HIV for Health Care providers”, Satellite Symposium, XI International Conference on AIDS, Vancouver, BC, July 5th, 1996.
  226. “HIV Disease in Women and Children“ with Dr J Forbes, Thursday Evening Lecture Series for Dental Hygienists, Continuing Dental Education, University of British Columbia, Vancouver, BC, September 26, 1996.
  227. “Emerging and Re-Emerging Infections in Dentistry” with Riben PD,  Continuing Dental Education, Faculty of  Medicine And Oral Health Sciences, University of Alberta, Edmonton, AB, November 30, 1996.
  228. Moderator: “Interdisciplinary education in the health and social scenes: lessons learned” in Building a Bridge: Challenges  and Opportunities in Interdisciplinary HIV/AIDS Education, Ottawa, Ontario, November 30 – December 2, 1996.
  229. “Dental treatment of the cancer patient”,  American Academy of Oral Medicine and Louisiana State University,  New Orleans, LA, December 7, 1996.
  230. “Oncology: The role of the dentist: recognition, diagnosis, oral care”, BC Dental Meeting at Vancouver, March 13, 1997.
  231. “Oral cancer: your responsibilities; Common Oral Lesions: when you hear hoof beats, think of horses, not zebras”, 130th Annual Spring Meeting, Ontario Dental Assoc, Toronto, ON  May 1, 1997.
  232. “Incidence of periodontal disease in radiated versus non-irradiated sites”; “A long term follow-up study of patients with mandibular post-radiation osteonecrosis”,  Int Soc for Oral Oncol, Chicago, IL, June 13, 1997.
  233. “Oral complications in immunocompromised patients”, Distinguished Faculty Series in HIV, Health Services Central Region, Health Care Training Dept., Jackson, MI, August 12, 1997.
  234. “New look at HIV: Oropharyngeal opportunistic infections” in 15th Annual Infectious Disease Update.  Distinguished Faculty series in HIV, Providence Hospital, Southfield, MI, August 13, 1997.
  235. “Oral management of infection in HIV/AIDS”, Grand Rounds, Dept. of Infectious Disease, Henry Ford Hospital, Detroit, MI, August 13, 1997.
  236. “Risk Management: a Panel Discussion” with Mr. K. Glasner, Dr. R. Greenfeld, Dr. L.P. Rossoff at the Midwinter Clinic, Vancouver & District Dental Society, Vancouver, BC, Canada, December 12, 1997.
  237. “Current practices for Oral Management of the head & Neck Radiation Patient (Pre-cancer therapy, during therapy, and post-therapy).”  10th International Symposium, Supportive Care in Cancer.  San Antonio, Texas, March 14, 1998.
  238. “Mucositis: Prevention and Management in Contemporary Issues in Head & Neck Cancer”.  14th Annual Head & Neck Conference, American Cancer Society, La Jolla, California, March 27, 1998.
  239. “Oral management of the Cancer Patient”.  Annual Meeting of Washington State Society of Oral & Maxillofacial Surgeons, Blaine, Washington, Mary 16, 1998.
  240. “Oral Medicine Update”. Mid-Winter Meeting, Mount Baker District Dental Society, Bellingham, Washington, February 26, 1999.
  241. “Clinical Case Presentations: Squamous cell carcinoma following Bone Marrow Transplantation” F Lozada-Nur, MM Schubert, JB Epstein. Annual Meeting of the American Academy of Oral Medicine, Seattle, WA April 30, 1999.
  242. “Early detection of Head and Neck Malignancies” LR Eversole, JB Epstein, S Silverman Jr. Annual Meeting of the American Academy of Oral Medicine Seattle, WA, May 1, 1999
  243. “Premalignant Lesions” JB Epstein. Oral Medicine: Update in the Diagnosis and Management of Oral Lesions, Facial Pain, Salivary Disorders and other Oral Complaints, Continuing Dental Education, University of Washington, Seattle, WA, January 21, 2000.
  244. “Oral Malignancies” JB Epstein. Oral Medicine: Update in the Diagnosis and Management of Oral Lesions, Facial Pain, Salivary Disorders and other Oral Complaints, Continuing Dental Education, University of Washington, Seattle, WA, January 21, 2000
  245. “Oral Precancer and Cancer” in: Oral Medicine Update. Continuing Dental Education, University of Washington, Seattle, WA, January 21st, 2000.
  246. “Orofacial Pain in Cancer Patients”. Mayo Clinic, Rochester MN, January 2000
  247. “Clinical Implications of the Molecular Study of Oral Cancer.” New York University, New York, NY, February 4th, 2000.
  248. “A New Tool for Measuring Oral Mucositis – The Modified Oral Mucositis Assessment Scale” in Oral Mucositis: Recent Advances in the Understanding of its Measurement, Health and Economic Impact and its Treatment. A Continuing Medical Education Satellite Lunch Symposium. Anaheim, CA., March 28th, 2000
  249. “Oral Mucositis: advances in assessment and management” Memorial Sloan-Kettering Cancer Center, New York, NY, April 17th, 2000.
  250. “Sore Mouth (New Perspectives in Managing Non-Dental, Intra-Oral Pain)” St. Joseph Hospital, Bellingham, WA, April 26th, 2000
  251. “Development of an understanding of the molecular basis of oral dysplasia” NIDCR, NIH, Bethesda MD, Oct 20, 2000.
  252. “What dental providers should know about oral cancer” Calgary and District Dental Society, Calgary Alta, Nov 24, 2000.
  253. “Oral mucositis in Cancer Patients: Progress in Understanding and Management”  Eastman Dental Hospital, University College of London, London UK, Feb 22, 2001.
  254. “Serious and uncommon gingival and periodontal lesions or all that is red is not gingivitis” Greater Vancouver Dental Hygienists Association, Vancouver BC, Feb 26, 2001.
  255. “Making sense of antibiotic coverage, and Update on Oral Cancer”. Mount Baker and District Dental Society Winter Meeting, Bellingham WA, March 16, 2001.
  256. A survey of current dental practitioner antibiotic use: focus on antibiotic use in HIV. Pacific/NW Aids Education and Training Center Asilomar Faculty Development Conference. Pacific Grove CA, April 10, 2001
  257. Direct supportive care for the benefit of patients pre- and postoperative radiotherapy and chemotherapy. 7th International Congress on Oral Cancer, Den Haag, The Netherlands April 26, 2001.
  258. Advances in the diagnosis of oral dysplastic and malignant lesions. College of Dentistry Seminar, University of Illinois at Chicago, Chicago Ill May 25, 2001
  259. New diagnostic, prognostic and treatment planning technology for the general practitioner. In: Dr. Robert and Kay Schattner Panel Discussion, American Academy of Oral Medicine and The European Academy of Oral Medicine in conjunction with Les Journees Dentaires Internatiaonales Du Quebec, Montreal Quebec, May 30, 2001.
  260. Oral cancer and premalignant oral lesions: dental professional responsibilities.  With Dr. E Truelove, and Dr. M. Schubert.  University of Washington, Continuing Dental Education, Seattle, WA, September 28, 2001
  261. Oncology and oral care: Early detection and diagnosis. Thompson Okanagan Dental Meeting, October 27, 2001, Kelowna, British Columbia.
  262. “A review of antibiotic use practices by dentists”.  In “Infection Control in Dentistry”.  Canadian Association for Clinical Microbiology and Infectious Diseases, Community and Hospital Infection Control Association, and Canadian Infectious Disease Society, Conjoint Annual Meeting, Victoria, British Columbia, Nov 7, 2001.
  263. Understanding the molecular biology of oral dysplasia and cancer.  Continuing Education, Saskatoon, Saskatchewan, Nov 10, 2001.
  264. Advances in the diagnosis of oral premalignant and malignant lesions.  Washington State Society of Prosthodontics, Seattle, WA. Jan 24, 2002.
  265. Temporomandibular disorders. City Wide Grand Rounds, Physical and Rehabilitation Medicine, University of British Columbia, GF Strong, Vancouver, BC, Jan 30, 2002
  266. TMD-Otolaryngology Connections.  City Wide Grand Rounds, Otolaryngology, University of British Columbia, Vancouver Hospital, Vancouver , BC, Mar 11, 2002.
  267. Head and Neck and Orofacial Neurologic Manifestations of HIV/AIDS. Pacific and Northwest AETC Teaching Conference, Asilomar, California April 9, 2002
  268. Oral lesions: things that go bump in the night. Greater Vancouver Dental Hygienists’ Society’s 29th Annual General Meeting, Vancouver, BC May 26, 2002.
  269. New Frontiers in Oral Medicine and Orofacial Pain.  J. Epstein and C. Greene. Chicago Dental Forum, Evanston IL Sept 17, 2002
  270. New Frontiers in Oral Medicine and Orofacial Pain.  J. Epstein and C. Greene. Westside Branch Chicago Dental Society, Oak Park, IL Dec 10, 2002.
  271. Advances in the diagnosis of premalignant and malignant oral lesions. Academic Center of Amsterdam (ACTA), Amsterdam, The Netherlands Nov 21, 2002
  272. Common oral lesions. Rosenfeld and Mandelaris Interdisciplinary Periodontal – Restorative Study Club, Park Ridge, IL, January 29, 2003.
  273. Cancer Treatment: The Oral Connection.  In 19th Annual Head and Neck Conference “The Head and Neck Connection”.  American Cancer Society. La Jolla, California, February 14, 2003
  274. Advances in Oral Medicine, Orofacial Pain, Oral Mucosal Disease and Oral Sensory Disorders.  with Dr. C. Greene and Dr. M. Grushka.  Chicago Dental Society Midwinter Meeting, Chicago ILL, March 1, 2003.
  275. Multidisciplinary Approach to the Management of Head and Neck Pain.  American Dental Educators Association, San Antonio March 9, 2003
  276. Advances in Diagnosis of Oral Premalignant Lesions. Grand Rounds, Department of Otolaryngology and Head and Neck Surgery, University of Illinois, Chicago, Illinois March 12, 2003.
  277. New Frontiers in Oral Medicine and Orofacial Pain at University of Illinois.  J. Epstein and C. Greene. Northside Branch Chicago Dental Society, Chicago, IL April 1, 2003
  278. Common Oral Lesions and Management of Cancer Patients. Upper Island Dental Society, Mount Washington, BC, April 5, 2003.
  279. Advances in the Diagnosis of Premalignant Oral Lesions. Brigham and Women’s Hospital and Harvard School of Dental Medicine.  May 9, 2003
  280. New Frontiers in Oral Medicine and Orofacial Pain at University of Illinois.  J. Epstein and C. Greene. Dental Arts Study Club, Chicago, IL May 27, 2003.
  281. Gingival and Periodontal Disease in Cancer Patients in: Assessment and Management of Dental/Periodontal Disease in Cancer Patients with Drs. M. Schubert and F. Spijkervet.  Europerio 4, Berlin, Germany June 20, 2003.
  282. Chronic Oral Complications of Cancer and Cancer Therapy, Workshop, Chairman with Dr. A. Keilbassa. Multinational Association for Supportive Care in Cancer and International Society for Oral Oncology. Berlin, Germany June 21, 2003.
  283. Management of Pain due to Oral Mucositis; Management of Hyposalivation.  In: Exploring Future Directions in Supportive Care of Oncology Patients. Abbott Oncology Workshop, San Diego CA, August 22-24, 2003
  284. Diagnosis of Oral Premalignant Lesions and Squamous Cell Carcinoma. Association for Dental Sciences, Republic of China, Annual Meeting, Taipei, Taiwan September 6 & 7, 2003.
  285. Orofacial Pain. Cooledge Club, Chicago Illinois, September 18, 2003.
  286. Mucositis in Cancer Therapies: Progress in understanding and patient management. Head and Neck Service, Clinical conference. Memorial Sloan-Kettering Cancer Center, New York, New York, October 16, 2003.
  287. Oral Oncology: The Oral Connection. Universidad Latina, Costa Rica, San Pedro, Costa Rica, Nov 10, 2003
  288. Orofacial Pain: Current Concepts of TMD and Other Conditions.  Drs. J. Epstein, M. Grushka, C. Greene, L. Mercuri. College of Dentistry, University of Illinois, Chicago, Illinois, November 15, 2003.
  289. Oral Malignancies in HIV Diseases.  Dental expert advisory committee. National Aids Education and Training Centers (NAETC). Chicago, Illinois, December 12, 2003
  290. Advances in Oral Medicine. Englewood Branch, Chicago Dental Society, Chicago Illinois, January 13, 2004.
  291. Advances in Oral Mucositis.  Rush University Medical Center, Section of Bone Marrow Transplant and Cell Therapy. Chicago Illinois, January 14, 2004
  292. Oral Medicine and Head and Neck Cancer from A (adenocarcinoma) to Z (zerostomia).  Diplomates Lecture, American Academy of Oral Medicine, Key Biscayne Florida April 22, 2004.
  293. Orofacial Pain in Oral Medicine Board Review.  Course Director: Capt .TJ. Canaan, Naval Postgraduate Dental School, Bethesda Maryland May 20, 2004.
  294. A Dentist Saves a Patient’s Life: Early Oral Cancer Detection and Tobacco Cessation, with Karen Crews. Michigan Dental Association Annual Session 2004. Detroit Michigan, May 22, 2004.
  295. Dental treatment decision-making during head and neck radiation therapy.  International Society for Oral Oncology Session, MASCC/ISOO 16th International Symposium, Supportive Care in Cancer Miami Beach Florida June 25, 2004
  296. Oral care protocols in oncology: A survey. Oral Care, Scientific Sessions. MASCC/ISOO 16th International Symposium, Supportive Care in Cancer Miami Beach Florida June 26, 2004.
  297. The Oral Cavity in HIV/AIDS.  Guest Lecture, Inaugural Ceremony, HIV/AIDS in Dental Practice. The University of the West Indies, JFK Auditorium, St Augustine, Trinidad July 6. 2004.
  298. Oral infections and their management in patients with HIV/AIDS; Oral neoplasms and other lesions in patients with HIV/AIDS and their management. In Training of Trainers Workshop in HIV/AIDS in Dental Practice. HIV/AIDS in Dental Practice. The University of the West Indies, JFK Auditorium, St Augustine, Trinidad July 8. 2004.
  299. Clinical aids and diagnostic adjuncts for oral premalignant lesions and squamous cell carcinoma. In: Instructional Course: Screening and Early Diagnosis with Dr. W. Koch at: 6th International Conference on Head and Neck Cancer Evaluation; American Head and Neck Society; Washington, D.C. August 7, 2004.
  300. Oral Mucositis: The Most Distressing Side Effect of Cancer Therapy. In “Oral Complications in the Oncology Patient”. The National Meeting of the Israeli Society of Oral Medicine, Tel Aviv, Israel, October 14, 2004.
  301. Head and Neck Cancer: The Oral Connection.  In Oral Complications in the Oncology Patient”. The National Meeting of the Israeli Society of Oral Medicine, Tel Aviv, Israel, October 15, 2004.
  302. Issues with your mouth, salivary glands and teeth from radiation treatment.  7th International Thyroid Cancer Survivors’ Conference.  Deerfield Illinois October 24, 2004.
  303. Cancer and Facial Pain: The Oral Connection, with Dr. S. Mehta. Fraser Valley Dental Society, White Rock British Columbia November 3, 2004.
  304. Management of Oral Mucositis.  CuraGen Corporation C421 Investigators Meeting, CuraGen Corporation, Tuscon, AZ November 6, 7 2004
  305. Oral Mucositis: Pathobiology and Scope of the Problem. In: Benzydamine, National Oncology Nurse Advisory Board Meeting, McNeil Consumer & Specialty Pharmaceuticals, Coral Gables, FL, Dec 10, 2004.
  306. Dentist saves patient’s life:!  Early Oral cancer detection and tobacco use cessation, with Dr. N. Burzynski,. Missouri Dental Association: Winter Session 2005, Columbia, Missouri Jan 21, 2005
  307. Oral Complications of Thyroid Cancer. Endocrinology Grand Rounds, Department of Medicine, College of Medicine, University of Illinois Chicago Illinois, Feb 1, 2005.
  308. Mucositis in Cancer Patients. Grand Rounds, Department of Otolaryngology/Head and Neck Surgery, College of Medicine, University of Illinois, Chicago IL, Feb 2, 2005.
  309. Oral Diagnosis, Oral Medicine and Orofacial Pain: Current Updates.  With Drs. R. Botto, C. Greene, G. Klasser, H. Sroussi, R. Jurevic, T. Toepke. The Chicago Dental Society 140th , Midwinter Meeting Chicago Illinois, Feb 23, 2005.
  310. Orofacial Pain in Cancer Patients: Mechanisms and Management. Samuel Charles Miller Distinguished Lecture, American Academy of Oral Medicine, American Academy of Orofacial Pain 2005 Joint Annual Meeting, Phoenix AZ, April 14, 2005.
  311. Malignancies in HIV.  Midwest AIDS Training Center (MATEC) University of Illinois, Chicago Illinois, April 20, 2005.
  312. The Role of the Dentist in the Prevention and Detection of Oral Cancer.  With Dr. J. Schwartz; Continuing Education, college of Dentistry, University of Illinois, May 4, 2005.
  313. Cancer Care: The Role of Oral Care; Common Oral Lesions.  Northwest BC Dental Society Annual Spring Meeting, Terrace BC May 28, 29, 2005 .
  314. Early Diagnosis of Cancers involving the Head and Neck and Oral Cavity, Session Chair with Dr. S. Silverman Jr and Professor Isaac van der Waal. International Society of Oral Oncology Continuing Education Program at Supportive Care in Cancer MASCC/ISOO 17th International Symposium, Geneva, Switzerland June 30, 2005.
  315. Orofacial Pain in Cancer Patients, Epidemiology, Clinical Care. Supportive Care in Cancer MASCC/ISOO 17th International Symposium, Geneva, Switzerland July 2, 2005.
  316. Cancer Treatment and the Dental Patient: Cancer treatment the oral connection; Advances in the diagnosis of oral cancer.  At: 57th Annual Midwest Seminar of Dental Medicine, Baileys Harbor, Door County, Wisconsin Sept 19, 2005.
  317. Cancer in Dental Practice in Drugs, Diseases and Dentistry with Drs., B. Blasberg, W. Carpenter, M. Glick and P. Jacobsen.  Arthur A. Dugoni School of Dentistry, University of the Pacific, San Francisco, CA Oct 21, 2005.
  318. Cancer Care: The Oral Connection. Sunstar Corp, Kyoto, Japan, Oct 25, 2005.
  319. Clinical Review: Oral Care of Cancer Patients.  Japanese Society of Clinical Oncology, 43rd Annual Meeting. Nagoya Japan, Oct 27, 2005.
  320. Oral Management of Oral Complications Induced by Cancer Therapy. Hokkaido Association of Dental Science, Hokkaido University School of Dentistry. Sapporo, Japan Oct 28, 2005
  321. Clinical Care for Cancer Patients. Annual William Wolfe Cancer Symposium, School of Dentistry and Kentucky Cancer Program, University of Louisville, Louisville, KY, Nov 11, 2005.
  322. Tolonium chloride and early cancer diagnosis and Panel Discussion with Drs. S. Silverman Jr. and J. Sciubba.  Zila-401 Investigators Meeting, Scottsdale, AZ Dec 9, 2005.
  323. Orofacial pain related to mucositis and clinical consequences,  in Symposium Supportive Care in Cancer Patients, Universitair Medisch Centrum Groningen, Groningen, The Netherlands, Dec 13, 2005.
  324. Biologic Aspects of Mucosits: in Mucositis in Febrile Neutropenia.  8th International Symposium on Febrile Neutropenia, Athens, Greece, Jan 27, 2006.
  325. Early recognition, diagnosis and treatment of oral premalignant lesions and squamous cell carcinoma.  Implement Hygiene Study Club. Dr. Mandelaris, Lutheran General Hospital, Chicago Ill, March 22, 2006.
  326. Oral Mucositis Training Assessments in CLN-12 Investigator Meeting, CuraGen Corp; Scottsdale, AZ April 6-7, 2006.
  327. Management of Dysplastic Lesions of the Oral Mucosa. With Saman Warnakulasuriya, Cesar Migliorati.  American Academy of Oral Medicine; World Update on Oral Medicine. Annual meeting. San Juan Puerto Rico, May 4, 2006.
  328. Bisphosphonates and Osteonecrosis of the Jaws. Mount Baker and District Dental Society, Bellingham WA, May 30, 2006.
  329. Bisphosphonate Osteonecrosis. St. Joseph Hospital, Continuing Medical Education. Bellingham, WA, May 31, 2006.
  330. Patient-centered Care: Requirements for Oral Supportive Care in Oncology.  Chair, with E. Grayzel, M. Katz, D. McGuire, M. Brennan, M. Stokman, D. Saunders, C. Migliorati. Multinational Society for Supportive Care in Cancer/ International  Society for  Oral Oncology, 18th International Symposium, Toronto, Ont, June 22, 2006.
  331. Mechanisms and Approaches for Management of Oral Mucositis Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Medical Rounds, Chicago, IL Aug 7, 2006.
  332. Detection and evaluation of oral premalignant and malignant lesions through visualization techniques in Detection of Oral Premalignant and Malignant Lesions: Visualization, Oral fluids, Cells and Tissues with Drs J. Calafano, D. Wong, J. Schwartz, University of Illinois, U24 Research Grant, Transforming Research at the College of Dentistry, American Dental Association, Chicago IL, Aug 16, 2006.
  333. Early Diagnosis of Premalignant Lesions. Chicago Dental Society, Northwest Suburban Branch, Arlington Heights, IL, Oct 10, 2006.
  334. Detection and Evaluation of Oral Premalignant and Malignant Lesions through Visualization Techniques: Toluidine Blue. In “Early Detection of Oral Cancer”, with Dr. M. Kahn, Dr. W. Balanoff and E. Grayzel.  Sponsored pre-meeting program, American Dental Association.  Las Vegas, Nevada, Oct 15, 2006
  335. Early Oral Cancer Detection and Tobacco use Cessation. with Dr. Karen Crews. Seattle-King County Dental Society and the American Dental Association. Seattle, WA, Nov 10, 2006
  336. Treatment-induced oral and gastrointestinal toxicity in patients with cancer. Department of Dermatology Rounds, Northwestern University, Chicago, Ill, Nov 20, 2006
  337. Oral and dental care in cancer patients. Tokyo Dental College, Chiba Prefecture, Chiba, Japan Nov 30, 2006.
  338. Changes in the oral manifestations of HIV disease. Japan Annual Meeting for AIDS Research. Dec 1, 2006.
  339. Changes in the oral manifestations of HIV and Cancer. Japan Annual Meeting of Dental Research for HIV/AIDS patients. International Medical Center of Japan, Tokyo, Japan Dec 3, 2006.
  340. Changes in the oral manifestations of HIV and Cancer. Okayama University, Department of Oral Surgery and Medicine.  Okayama, Japan, Dec 5, 2006.
  341. Changes in the oral manifestations of HIV Disease. HIV Conference of Dental Research, Osaka, Japan Dec 6, 2006.
  342. Oral Disease in HIV: Diagnosis and approach to management. HIV Conference of Dental Research in Hokkaido, Sapporo, Japan Dec 7, 2006
  343. Oral Mucositis: Pathogenesis and current management guidelines. Hokkaido Association of Dental Science. Hokkaido University, Hokkaido, Japan Dec 8, 2006.
  344. Analysis of oral mucosal biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. In Head and Neck Cancer Diagnosis; Multidisciplinary Head and Neck Symposium. Co-sponsored by ASTRO, ASCO, AHNS. Rancho Mirage CA, Jan 19, 2007.
  345. Cancer: role of the oral health care provider.  Grand Rounds. Division of Oral Surgery and Dentistry, Loyola, Maywood, Illinois March 26, 2007.
  346. Open your mouth: oral manifestations of HIV for primary care. with Dr. H. Sroussi, Mid-West Aids Treatment and Education Center (MATEC), Chicago, Illinois, April 3, 2007
  347. Mucositis.  In Management of chemotherapy-related complications: a case-based approach to the management of mucositis, hematologic sequelae, and chemotherapy-related bone loss, with Drs. R. Natale and C. Russell.  Los Angeles, CA April 17, 2007.
  348. Analysis of oral mucosal biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue, JB Epstein, S. Silverman Jr, JD Epstein, S. Lonky. American Academy of Oral Medicine, Annual Meeting, San Diego, CA April 20, 2007.
  349. Mucositis.  In Management of chemotherapy-related complications: a case-based approach to the management of mucositis, hematologic sequelae, and chemotherapy-related bone loss. with Drs. R. Feld and  J Gralow.  Seattle, WA April 24, 2007.
  350. Orofacial pain in cancer patients” in Symposium, Oral supportive care in cancer patients: Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology at First World Congress of the International Academy of Oral Oncology (IAOO), Oral Oncology: A Global Challenge, Amsterdam, The Netherlands, May 18, 2007
  351. Discussant, Multinational Association of Supportive Care in Cancer/ International Society of Oral Oncology. Mucositis Research Workshop, St. Gallen Switzerland, June 25, 2007.
  352. Early detection of oral premalignant and malignant lesions: Current and developing technologies. Chicago DCP Practices, Oak Brook, Illinois, August 31, 2007.
  353. Mucositis in cancer Patients.  Grand Rounds, Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Feinberg School of Medicine, Chicago, Illinois,  September 21, 2007.
  354. Practical approaches for the prevention, diagnosis and management of patients with oral cancer. With Drs. C-A Murdoch-Kinch and K. Crews. 148th Annual Meeting of the American Dental Association, San Francisco CA, September 27, 2007.
  355. Sequelae and complications of radiotherapy: prevention and management; Mucositis; Osteoradionecrosis in: Oral Cancer: Challenges and Solutions. Eastman Dental Institute, London UK, Elesevier, International Association of Oral Oncology. October 6, 2007.
  356. Innovaciones en el tratamiento de la mucositis oral. XXV Congreso Nacional de Oncoligia. Tuxtla Gutierrez, Chiapas, Mexico. Oct 27, 2007
  357. Oral/Dental Care for Cancer Patients! Annual Wolfe Cancer Symposium. University of Louisville.  Louisville, KY. November 8, 2007.
  358. Mucositis in Multinational Association for Supportive Care Cancer, Skin Toxicity Study Group: Development of a grading scale for EGFRI toxicities project. Chicago, IL. November 15, 2007
  359. Adjuncts for the Detection and Diagnosis of Oral Premalignant and Malignant Lesions.  Alpha Omega, 100th Year Anniversary, Vancouver, BC, November 19, 2007.
  360. Bisphosphonate Osteonecrosis. Dental Arts Club, Westmont, IL, November 27, 2007
  361. Erbitux: Use, toxicities and treatment of head and neck cancer. With Dr. M. Chambers. Endo Oral Mucositis Steering Committee, Boston, MA December 3, 2007.
  362. Gingivitis and Periodontitis in Alzheimer’s Disease. Phase 2, Randomized, double-blind, placebo-controlled, dose-ranging, safety and efficacy study of oral ELND005 (AZD-103) in Alzheimer’s Disease: Elan Investigators Meeting, Chandler, AZ February 9, 2008
  363. Management of Saliva in Cancer Patients in: Oral Health in Cancer Therapy Conference.  Dental Oncology Education Program, Texas, Texas A&M Health Sciences Center, Baylor College of Dentistry, Dallas, Texas, February 22, 2008.
  364. Diagnosis of Malignant and Non-malignant Oral Lesions.  American Academy of Fixed Prosthodontics 57th Annual Scientific Session, Chicago, Illinois, February 23, 2008.
  365. Advances in Diagnosis of Oral Premalignant Lesions. Heartland Health Outreach and Heartland International Health Center Primary and Dental Providers.  Chicago, Illinois April 1, 2008.
  366. Advances in Diagnosis of Oral Cancer. City of Hope, Head and Neck Tumor Board, Duarte, CA April 9, 2008
  367. Cancer and It’s Implications for the Orofacial Pain Practitioner. Annual Meeting, American Academy of Orofacial Pain, Los Angeles, CA, April 10, 2008.
  368. Zometa in the treatment of bone metastases. With Dr. J. Berenson. Pasadena, CA, April 16, 2008.
  369. Oral malignancies associated with HIV. In HIV and Oral Disease: Update 2008.  American Academy of Oral medicine, Annual Meeting, Scottsdale, AZ May 2, 2008
  370. Oral cancer screening technology: The supporting science. American Association of Dental Consultants, Spring Workshop. Fountain Hills, AZ May 8, 200
  371. Advances in the treatment of oral mucositis and xerostomia. Forest park, Illinois. May 22, 2008.
  372. Cancer prevention and premalignancy. With Dr. Terry Day. Lunch with the Professors. 7th International Conference on Head and Neck Cancer, San Francisco, CA July 20, 2008.
  373. Mucositis. Northwestern Department of Dermatology CME Grand Rounds Educational Seminar, Northwestern Memorial Hospital, Chicago, IL. Aug 27, 2008.
  374. Mucositis in cancer patients: Recent advances and current guidelines. Medical Grand Rounds, City of Hope, Duarte, CA. Sept 2, 2008
  375. Head and Neck Cancer: Overall oral care in head and neck cancer. Fourth Annual Chicago Supportive Oncology Conference. Chicago, IL Oct 16, 2008.
  376. Oral Oncology from Recognition to Care following Treatment. Crystal Lake Excellence Study Club. Crystal Lake, IL Oct 17, 2008
  377. Advances in the Treatment of Oral Mucositis and Xerostomia, EUSA Pharmaceuticals Inc, Shaw’s Crab House, Chicago, IL Oct 30, 2008.
  378. Oral and Dental Care of Cancer Patients. Advanced Practice Nursing Conference, Oncology Nursing Society Annual Meeting, Seattle WA, Nov 14, 2008.
  379. Benefits of Bisphosphonate therapy vs Frequency of Oral Complications: An Education Primer for Dental Professionals. Novartis Web Conference. Nov 18, 2008.
  380. Oral malignancies associated with HIV. Midwest AIDS Training and Education Center, Dental Teleconference. Dec 3, 2008.
  381. Benefits of Bisphosphonate therapy vs Frequency of Oral Complications: An Education Primer for Dental Professionals. Novartis Web Conference. Dec 10, 2008.
  382. Benefits of Bisphosphonate therapy vs Frequency of Oral Complications: An Education Primer for Dental Professionals. Novartis Web Conference. Dec 16, 2008.
  383. Early detection of oral cancer. Lake County Dental Society, Gurnee, Illinois. Jan 6, 2009.
  384. Oral complications in Oncology Care. Grand Rounds, John H. Stroger, Jr. Hospital of Cook County Hospital, Chicago Illinois, Jan 15, 2009
  385. Oral and Dental Care of Cancer Patients. Rounds, Department of Dentistry, Cedars Sinai Medical Center, Los Angeles, CA, Jan 20, 2009.
  386. Benefits of bisphospohonate therapy versus risks of oral complications. Pomona Valley Cancer Care Center Rounds, Pomona, CA Jan 21, 2009.
  387. Benefits of bisphospohonate therapy versus risks of oral complications. Novartis Oncology. Rancho Mirage, CA Jan 21, 2009.
  388. Benefits of bisphospohonate therapy versus risks of oral complications. With Dr. E. Carrier, Novartis Oncology, La Jolla, CA, Jan 22, 2009
  389. Acute and Chronic Pain in Oral Complications of Emerging Cancer Therapies with Drs. B. Schmidt, C. Miaskowski, M. Schubert, D. McGuire, E. Eliav, L. Elting. April 14/15, 2009; Bethesda, Md.
  390. Advances in Oral Health in the Oncology Setting:  Moving Beyond Mucositis. EUSA Pharma, Tru Restaurant, Chicago, Il, Apr 20, 2009.
  391. Xerostomia, Jonathan A. Ship Diplomates Lecture, Oral Medicine in the Aging Population, American Academy of Oral Medicine, Annual Meeting, Miami, Fl, Apr 30, 2009.
  392. U.S. House of Representatives, Committee on Veteran Affairs: Subcommittee Hearing on “Innovative Technology and Treatments.” with D. Bethune, Drs. D. Sidransky and W. Balanoff. Washington, D.C.  May 13, 2009
  393. Post-radiation oral health issues and management. In: Management of the long-term toxicities of head and neck cancer treatment. with Dr. B.A. Murphy and S.H. Ridner, American Society of Clinical Oncology Annual ‘09 Meeting, Orange County Convention Center, Orlando, FL. June 1, 2009.
  394. Report of the Pain Section of the Oral Care Study Section, International Society of Oral Oncology, Rome, Italy June 26, 2009.
  395. Detection of Oral Premalignant Disease and Oral Squamous Cell Carcinoma-clinical experience. Reunion de consenso sobre sistemas de deteccion de precancer y cancer oral basados en sistemas de ilumnation. Dignostico precoz del Cancer oral desde la Odonotologia general en Espana. Moderator Dr. Rodroiqurz Lozano, Consejo Dentistas de Espana, Madrid, Spain, July 4, 2009.
  396. Prevention and management of xerostomia: in Supportive Care Seminar, 2nd World Congress of the International Academy of Oral Oncology, Toronto, Ont. July 11, 2009.
  397. In good taste. Lake County Dental Society, Gurnee, Illinois, Oct 6, 2009.
  398. Benefits of Bisphosphonate therapy vs Frequency of Oral Complications: An Education Primer for Dental Professionals. Novartis Pharmaceuticals Inc. Houston Texas. Oct 7, 2009.
  399. Oral Cancer: Early detection, and Dental Therapeutics. The Dental Forum of Milwaukee. Milwaukee, Wisconsin, Oct 9, 2009.
  400. Oral Cancer: Detection, Treatment and Rehabilitation. With Dr, D. Reisberg. Boston University, Henry Goldman School of Dental Medicine, Division of Continuing Education. Boston, MA Nov 13, 2009.
  401. A tasty topic. Alpha Omega Dental Fraternity, Vancouver, BC Jan 18, 2010.
  402. The critical role of oral care in cancer therapy. Southwest Dental Conference, Dallas, TX Jan 22, 2010.
  403. Detection and management of oral premalignant lesions and oral squamous cell carcinoma. Southwest Dental Conference, Dallas, TX Jan 22, 2010
  404. In good taste. New Jersey Dental School Seminar. University of Medicine and Dentistry, New Jersey, Newark, NJ Feb 9, 2010
  405. Optomizing Oral Cancer Evaluation and Managing the Oral Complications of Cancer Therapy. With Dr. N. Rhodus. Chicago Dental Society, 145th MidWinter Meeting, Chicago, Illinois, Feb 27, 2010
  406. Pain and Burning Mouth in Cancer Patients. 22nd Annual Meeting on Special Care Dentistry, Chicago, Illinois. Mar 28, 2010.
  407. Mucosal and Epidermal Toxicity: What do they have in common? How do they differ? In: Mucodermal toxicity, Parrallel Session, Multinational Association for Supportive Care in Cancer, International society for Oral Oncology Annual International Symposium. Vancouver, BC, June 25, 2010.
  408. Burning Mouth Syndrome: A consensus development of key criteria to standardize data collection. An official Satellite Symposium of the 13th World Congress on Pain, Meeting chair, with Drs. E. Eliav, and G. Klasser, Montreal, Canada, August 28, 2010.
  409. Oral Cancer Detection: The Role of the General Dentist. Ege University, 14th International Dental Scientific Congress, Izmir, Turkey, October 1, 2010.
  410. Epidemioogia y caracteristicas clinicas de la mucositis bucal. Dolor asociado a la mucositis and Diagnostico diferencial, escalas de medicion e impacto en la sobrevida de los pacientes con mucositis. Efectos adversos asociados al tratamiento oncologico: repercusiones clinicas y sociales. Universidad Autonoma Metroploitana, Mexico City, Mecixo Jan 25, 2011.
  411. Oral Care of Cancer Survivors. Yankee Dental Congress 36. Boston Convention Center, Jan 29, 2011.
  412. Managing the oral cavity during cancer treatments. With Papas A, Singh M. Yankee Dental Congress 36. Boston Convention Center, Jan 29, 2011.
  413. Osteolytic Inhibitors and Dental Care. Chicago Dental Forum. March 15, 2011, Chicago, Illinois.
  414. Osteolytic inhibitors, clinical use and clinical oral management. Odontographic Society of Chicago. April 4, 2011, Chicago, Illinois
  415. Oral Care of Cancer Patients from detection to survivorship. Ontario Dental Association, Annual Scientific Meeting, Toronto, Ontario, April 28, 2011.
  416. Salivation in Head and Neck Cancer Patients in: Supportive Care in Radiotherapy. Multinational Association for Supportive Care in Cancer/ International Society of Oral Oncology, 2011 Symposium. Athens, Greece June 24, 2011.
  417. General Principles of Pre-cancer Treatment Oral Care. In: International Association of Oral Oncology continuing Education Course. Athens, Greece June 25, 2011.
  418. Oral Care in Cancer Patients. Hematoloty/Oncology Grand Rounds, Division of Hematology/Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, July 12, 2011.
  419. Oral care of the cancer patient: From diagnosis to survivorship. The Saskatchewan Dental Professions Annual Scientific Session, Regina Saskatchewan Sept 16, 2011.
  420. Osteolytic inhibitors and dental care. JV Pissano Annual Continuing Education Program. Schamburg, IL, Sept 30, 2011.
  421. Global Oral Stomatitis Expert Input Forum. Merck, Lisbon Portugal, Oct 5/6, 2011.
  422. Oral Care of Cancer Patients: From Diagnosis to Survivorship. University of Calgary, Continuing Education, Foothills Hospital, Calgary Alberta Oct 15, 2011.
  423. Cancer Survivorship and Oral Care. American Academy of Maxillofacial Prothetics 59th Annual Meeting, Scottsdale, AZ Oct 31, 2011.
  424. Taste: Good, bad, none. Division of Dentistry Rounds. Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, Nov 10, 2011.
  425. Oral complications following cancer therapy. Mount Baker Dental Society; Bellingham, WA, Jan 17, 2012.
  426. Late Oral Effects of Head and Neck Cancer Therapy. In: Supportive Care During and After Treatment, Moderators: Barbara Murphy, Gerry Funk. Muldisciplinary Head and Neck Cancer Symposium. American Head and Neck Society, American Society of Clinical Oncology, American Society of Therapeutic Radiation Oncology. 2012 Symposium, Phoenix AZ Jan 27, 2012.
  427. Taste: Good, bad or none. Southern California Academy of Oral Pathology. Los Angeles, CA Feb 15, 2012.
  428. Oral care of head and neck cancer survivors. Alpha Omega, Vancouver BC, Feb 20, 2012.
  429. Osteolytic Inhibitors and Dental Care. Dr. David Anson Study Club, Los Angeles, CA March 26, 2012.
  430. Saliva: quantity and quality in head and neck cancer. Grand Rounds, Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, CA April 2, 2012.
  431. Essential strategies for tobacco cessation in dental practice. With Peter Selby. Royal College of Dental Surgeons of Ontario QA Program. Ontario Dental Association, Annual Spring Meeting 12, May 10, 2012.
  432. Tobacco: dentistry and oral health. Royal College of Dental Surgeons of Ontario QA Program. Ontario Dental Association, Annual Spring Meeting 12, May 11, 2012.
  433. Oral Changes with Tobacco use. Lunch and Learn Webinar Series, Center for Addiction and Mental Health, Toronto, Ontario Sept 26, 2012.
  434. Mucositis in Radiation Therapy. Grand Rounds, Radiation Oncology, City of Hope National Medical Center, Duarte, CA June 15, 2012
  435. Oral changes with tobacco use: a focus on tobacco dentistry. In: Tobacco Cessation Interventions, Lunch and Learn Seminar Series for Physicians, Family Health Teams and other Health/Allied Health Practitioners: Session 6. CAMH: Center for Addiction and Mental Health, Ontario. September 26, 2012.
  436. Recommendations for oral assessment and management prior to transplant and survivorship. Hematologic Neoplasia Program Rounds, City of Hope, Duarte, CA, September 27, 2012.
  437. Saliva: not just a dry topic; Taste: Good, Bad or None. Dr. David Anson Study Club, Los Angeles, CA. October 1, 2012.
  438. Mucositis. In: First Dermatologic Care in Oncology Symposium, Memorial Sloan Kettering Cancer Center, New York, NY. October 12, 2012.
  439. Taste in Oncology. Division of Oral Medicine Seminar, Brigham and Womens Hospital, Boston, MA. November 7, 2012.
  440. Oral Cancer Seminar. With Dr. Daniel Petrisor. Comprehensive Treatment Planning Study Club. Beverly Hills Four Seasons Hotel, Beverly Hills, CA Nov 9, 10, 2012.
  441. Management of burning mouth syndrome. Master Clinicians Series; Pala Mesa Spear Study Club North & South, Fallbrook, CA, December 19, 2012.
  442. The role of dental care in oncology: Acute andchronic complications. Mount Baker and District Dental Society, Bellingham, WA, March 11, 2013.
  443. Your mouth and chronic graft versus hostdisease. In: Celebrating a second chance at life survivorship symposium. BMTinfonet.org Costa Mesa, CA, April 21, 2013.
  444. HPV: A developing epidemic of head and neck cancer? and Bisphosphonates and new osteolytic inhibitors: update on advances in medical care and impact upon dental care. Los Angeles and District Dental Society; Los Angeles, CA, May 8, 2013.
  445. HPV and Cancer: What we know, what we don’tknow. Alpha Omega, Vancouver, BC, May 13, 2013.
  446. Osteonecrosis of the jaw: continuing developments. Medical-Dental Study Club, Vancouver BC. May 16, 2013.
  447. Xerostomia: more than a dry mouth. Division of Rheumatology, Cedars-Sinai Medical Center. June 19, 2013.
  448. Acute oral and oropharyngeal complications, in: Adverse effects of treatment of head and neck cancer. Amsterdam, The Netherlands, June 24, 2013.
  449. Chronic oral and oropharyngeal complications, in: Adverse effects of treatment of head and neck cancer. Amsterdam, The Netherlands, June 24, 2013.
  450. Mucositis Secondary to Newer Chemotherapy Regimens, in Mucositis: an interdisciplinary perspective and update. Multinational Association for Supportive Care in Cancer. Berlin, Germany, June 28, 2013.
  451. Targeted Therapy in Elderly: Special Attention to Mucosal Adverse Events in Older Adult Cancer Patients. Workshop Skin Toxicity Study Group and Geriatric Study Group, Multinational Association for Supportive Care in Cancer. Berlin, Germany, June 27, 2013.
  452. In Good Taste: A Dinner Presentation. Advanced Treatment Planning Study Group, Dr. D. Galen, Beverly Hills, CA, Oct 14, 2013.
  453. The needs of dry mouth sufferers: Polypharnacy, Products. GSK Dry Mouth Advisory Board, London, UK Oct 21, 22, 2013.
  454. Oral care in cancer patients. Pasadena Women’s Study Group, Dr. L. Carpenter. Pasadena, CA Nov 22, 2013.
  455. In good taste. Medical-Dental Study Club, Vancouver BC, Jan 15, 2014.
  456. Osteonecrosis of the jaw in oncology: Risk, prevention and management.  Medical Grand Rounds, City of Hope, Duarte, CA Jan 21, 2014.
  457. Supportive Care During and Following Cancer Therapy: What do we do for a dry mouth? Multidisciplinary Head and Neck Cancer Symposium. American Society for Radiation Oncology, American Society of Clinical Oncology, American Head and Neck Society, Scottsdale, AZ, Feb 21, 2014.
  458. Oral care. Cancer Support Community Redondo Beach.  Redondo Beach, CA Mar 1, 2014.
  459. Controversies in Oral Medicine: Burning mouth syndrome: Central or peripheral neuropath pain. with R. Balasubranian. In Frontiers in Oral Medicine Orlando 2014 in Conjunction with World Workshop in Oral Medicine, Orlando FL, April 10, 2014
  460. Oral Cancer Early Detection with S. Warnakulasuriya, R. Kerr, C. Farah. In Frontiers in Oral Medicine Orlando 2014 in Conjunction with World Workshop in Oral Medicine, Orlando FL April 11, 2014
  461. STDs and Dentistry: HPV and Head and Neck Cancer: Evolving Changes in the Disease, with D’Souza A, Huang S. Ontario Dental Association, Annual Spring Meeting Toronto Ont, May 7, 2014
  462. STDs and Dentistry: HPV and Head and Neck Cancer: Immunization: A Panel Discussion (What we know, Who we can protect and What is available), with D’Souza A, Huang S. Ontario Dental Association, Annual Spring Meeting Toronto Ont, May 7, 2014
  463. Common oral lesions. Medical-Dental Study Club, Vancouver BC, May 16, 2014
  464. Oral candidosis: a disease of the diseased. In Workshop: Oral problems in advanced cancer.MASCC/ISOO International Symposium on Supportive Care in Cancer. Miami, FL June 26, 2014
  465. Screening: Effective and Necessary? In Oral Cancer: awareness, early detection, and prevention (screening and prevention) with Day T, Kerr AR, Ondrey F. 5th World Congress of International Federation of Head and Neck Oncologic Societies and annual Meeting of the American Head and Neck Society. New York, NY July 29, 2014.
  466. Sex and the City.  Sexually transmitted disease and dentistry.  Mount Baker and District Dental Society, Bellingham, WA November 11, 2014.
  467. Mucositis. with Bensadoun R-J. in Cancer toxicity management Trasnatlantiques en Oncologie, Congress     International, Paris France, Nov 20-21, 2014.
  468. Common oral lesions: horses not zebras. Alpha Omega Seattle. Seattle WA Jan 11, 2015.
  469. HPV and Head and Neck Cancer: What we know, what we don’t know.  Medical-Dental Study Club Vancouver BC Jan 14, 2015.
  470. Sexually transmitted disease in dentistry: Oral diseases from old habits. Alpha Omega, Vancouver BC Feb 11, 2015.
  471. The detection and prevention of oral cancer.  With Dr. B. Larian.  Los Angeles and District Dental Society. Los Angeles CA Feb 24, 2015.
  472. CME/CDE for oral cancer and regional support meetings for patients and providers. SoCAL HNC Consortium, City of Hope, Duarte CA Mar 7, 2015
  473. Osteolytic inhibitors and dental care. CITED Dental Study Club. Vancouver, BC April 14, 2015.
  474. Oral cancer: a sexually transmitted disease. Sheila Hammer, Coordinator. Community Support Community/Gilda’s Club. Santa Monica CA Apr 30, 2015.
  475. Dental management of patients on osteolytic inhibitors.  Journees Dentaires Internationals du Quebec, 45th Congress Annuel, Palais des Congress de Montreal, Montreal, Canada May 25, 2015.
  476. Dental care of cancer patients. Journees Dentaires Internationals du Quebec, 45th Congress Annuel, Palais des Congress de Montreal, Montreal, Canada May 26, 2015.
  477. Management of oral and oropharyngeal complications associated with (chemo)radiation to the head and neck.  In: Symposium Oral Problems in Oncology Patients, Antoni van Leeuwenhoek Nederlands Kanker Insituut, Amsterdam, The Netherlands June 22, 2015.
  478. Dysphagia Workshop: Oral Issues: Dental health, mastication and xerostomia. Multinational Association for Supportive Care in Cancer Annual Meeting, Copenhagen, Denmark June 25, 2015.
  479. Clinical and adjunctive procedures to diagnose potentially malignant oral lesions.  Multinational Association for Supportive Care in Cancer Annual Meeting, Copenhagen, Denmark June 27, 2015.
  480. Oral care following head and neck cancer therapy: in: California Laryngectomee Conference, 1st Annual California Conference: Living life After a Laryngectomy. USC Department of Otolaryngology-Head and Neck Surgery.  University of Southern California, Los Angeles CA Oct 10, 2015.
  481. Saliva and taste. In 18th Annual Head and Neck Conference: Focus on Rehabilitation. Milton J. Dance, Jr. Head and Neck Center, Johns Hopkins, Greater Baltimore Medical Center, Baltimore, MD; Oct 16, 2015.
  482. Early detection of oral potentially malignant disorders.  Armenian American Medical Society.  Glendale, CA, Nov 11, 2015.
  483. Introduction to Dental Oncology. with Dr. D. Abbott. American Academy of Dental Oncology, Frisco Texas, Nov 13/14, 2015.
  484. Mucositis.  Trans-Atlantic Oncology (TAO) Congress: Cancer Toxicity Management, Institut Pasteur, Paris France Nov 20, 2015.
  485. Saliva: don’t it always seem to go, that you don’t know what you’ve got ‘til is gone.  Alpha Omega, Vancouver, BC Dec 8, 2015.
  486. Osteoradionecrosis. In Multidisciplinary Head and Neck Cancer Symposium. ASTRO, ASCO, American Head and Neck Society.  Scottsdale, AZ Feb 18, 2016.
  487. To screen or not to screen (Group 4); Global Oral Cancer Forum, Moderator with Paul Speight, A. Ross Kerr (Chair); New York, NY Mar 4, 2016.
  488. HPV and Cancer: What we know, What we don’t know. Pacific Dental Conference in conjunction with the Canadian Dental Association. Vancouver, BC Mar18, 2016.
  489. Forgotten oral functions: Saliva and Taste. Pacific Dental Conference in conjunction with the Canadian Dental Association. Vancouver, BC Mar18, 2016.
  490. Early detection of oral potentially malignant disorders: diagnosis and management. Pacific Dental Conference in conjunction with the Canadian Dental Association. Vancouver, BC Mar 19, 2016.
  491. Oral adverse effects of immune checkpoint inhibitors. In: Supportive Care in Immunotherapy. MASCC/ISOO Annual Meeting on Supportive Care in Cancer, Adelaide, Australia June 23, 2016.
  492. Saliva: You don’t know what you’ve got ‘til it’s gone. Alpha Omega San Fernando Valley Chapter, Encino, CA Sept 15, 2016.
  493. Oral Care of Head and Neck Cancer Patients: Survivorship. Annual Meeting of the American Academy of Maxillofacial Prosthetics, San Diego, CA Oct 2, 2016
  494. Evolutionary Biology and Cancer. Alpha Omega, Vancouver, BC Oct 18, 2016
  495. Oral toxicities of Immunotherapy. with Vincent Sibaud and Emmanuelle Vigarios. Transatlantic Oncology (TAO) Congress, Paris, France, Dec 8, 2016
  496. Making dental devices in: OSA: Treatment of the CPCP-intolerant patient.  with Dr. R. Gerber. Cedars-Sinai Otolaryngology: 2017. Los Angeles, CA, Mar 24, 2017
  497. Cancer Survivorship: Oral Care Following Cancer Therapy. In: Oral Cancer Series, with Dr. A. Asher, Los Angeles and District Dental Society, Los Angeles CA Apr 5, 2017
  498. Oral Care of Cancer Patients: From Diagnosis to Treatment. In: Oral Cancer Series, Los Angeles and District Dental Society, Los Angeles CA Apr 12, 2017
  499. What is my mouth trying to tell me? Hadassah-Wizo Organization of Canada.  Vancouver, BC Apr 19, 2017
  500. Evolutionary biology and cancer. Medical-Dental Study Club.  Royal Vancouver Yacht Club, Vancouver, BC May17, 2017.
  501. Plenary Session: Side Effects of Immunotherapy with David Warr, Mario Lacouture, Karin Jordan. MASCC/ISOO Annual Meeting, Washington, DC, June 23, 2017.
  502. Mucosotis: Outcome Measures; Targeted Therapy Mucositis.  MASCC/ISOO Annual Meeting, Washington, DC, June 23, 2017
  503. HPV and Head and Neck Cancer: Evolving Changes in the Disease;  Immunization: A panel discussion: What We Know Who We Can Protect and What is Available. with Drs. G. D’Souza and S. Huang. Ottawa Dental Society, Ottawa Ontario Nov 3, 2017
  504. Pain due to oral mucositis. TAO Conference. Cancer Toxicity Management (7th Program) Tolerance des tratements innovants.  Paris, France December 1, 2017
  505. Chronic Oral complications: Prevalence, Impact and Management. In: Stanford/Harvard TEP Course. Stanford University, Department of Otolaryngology, Head and Neck Surgery, Stanford CA March 16, 2018
  506. To screen or not to screen, that is the question.  With Ross Kerr, American Academy of Oral Medicine Annual Meeting, San Antonio, Texas, April 14, 2018
  507. Good taste, bad taste, no taste.  Specialty Forum. The Vancouver and District Dental Society.  Vancouver BC, April 16, 2018
  508. Photobiomodulation in Oral Oncology. Academy of Laser Dentistry. 25th Annual Conference, Orlando, FL, April 26, 2018
  509. Mucositis Working Group. with Arun Darbar, Annette Quinn and James Carroll. Academy of Laser Dentistry. 25th Annual Conference, Orlando, FL, April 26, 2018
  510. Differential diagnosis and management of oral GVHD.  In Symposium: Oral Graft versus Host Disease. Amsterdam UMC; Amsterdam, The Netherlands June 25, 2018
  511. Cancer Safety with  R-J Bensadoun, Michael Hamblin, Praveen Arany, Raj Nair, Andrei Barasch, Cesar Migloirati, Judith Raber. World Association for Laser Therapy (WALT) 12th International Symposium. Nice France, Oct 3, 2018
  512. PBM in Cancer supportive Care with R-J Bensadoun, Raj Lalla, Jean Klastersky, Jan Bjordal; Sharon Elad, Ken Hu, Andrei Barasch, Marie-Therese Genot, Arun Maiya, Cesar Migliorati, Judith Raber, Jolien Robijns, Eduardo Fregnani, Nathaniel Treister, Nathalie Pinto, Barbara Murphy. World Association for Laser Therapy (WALT) 12th International Symposium. Nice France, Oct 4, 2018
  513. Les mucosites. In Cancer Toxicity Management.  Trans-Atlantic Oncology Annual Congress.  Paris, France Nov 30, 2018.
  514. Common Oral Lesions. Vancouver Study Club, Vancouver, BC. Jan 17, 2019
  515. Benign Lesions; Common oral lesions: Horses not Zebras.  In: ENT for the non-ENT Provider.  Cedars-Sinai Health System, Los Angeles CA March 12, 2019
  516. Mystery diagnosis. House DDS. Multiple myeloma/osteonecrosis. Los Angeles District Dental Society. Los Angeles, CA March 26, 2019
  517. Common Oral Mucosal Lesions: Horses not Zebras. Medical-Dental Study Club, Vancouver BC, May 16, 2019
  518. Principles of pain management. In 11th Mucositis Research Workshop: Mucositis: Pain management.  MASCC/ISOO Annual Meeting, San Francisco, CA, June 21, 2019
  519. Reflections of an experienced investigator.  In: Young Investigators Parallel Session. MASCC/ISOO Annual Meeting, San Francisco, CA, June 22, 2019
  520. Oral Cancer: Prevention, Early diagnosis and Patient Management, with Inoue T, Lingen M, Nagy K.  Best of FDI. ADA/FDI World Dental Congress, San Fransicso, CA September 5, 2019.
  521. Skeptics guide to science, research, publications and the world in which we live. Division of Dentistry and Oral Surgery, Department of Surgery, Cedars-Sinai Health System, Los Angeles, CA, September 12, 2019.
  522. Hyposalivatioin in patients on immune checkpoint inhibitors. Southern California Head and Neck Consortium Retreat. UC San Diego, Moores Cancer Center. San Diego, CA October 5, 2019.
  523. Cytotoxic, targeted and immunotherapy oral complications: Changing landscape. Hematology Oncology Grand Rounds, Mount Sinai Medical Center, Icahn School of Medicine, New York, NY October 17, 2019
  524. Oral care of cancer survivors. Comprehensive Interdisciplinary Treatment and Education. Vancouver, BC. November 26, 2019.
  525. Supportive Care: Impact on Efficacy.  Moderator, with Dr. M. Appro, Dr. F. Roila. Cancer Toxicity Management (CTM) Meeting.  Paris, France December 6, 2019.
  526. 360 ⁰ Management: Myth or Reality.  Moderator with Dr. R Berman, Pr S. Kaasa, Dr. A Antonuzzo, Dr M. Saghatchian, Dr. M. Pterovic. Cancer Toxicity Management (CTM) Meeting.  Paris, France December 6, 2019.
  527. Oral Care in Cancer Survivors. Los Angeles Dental Society, Los Angeles, CA February 22, 2020
  528. COVID-19: What about history and what have we done. Cosmo Spectrum Study Club. Vancouver BC, October 16, 2020.
  529. Oral health for the head and neck cancer survivor.  With Carolyn Dee and Michael Moore  (Moderator).  Head and Neck Cancer Alliance and American Head and Neck Society, Webinar.   November 10, 2020
  530. Digestive toxicity and innovative treatments.  With: Dr. Paulo Bossi and Richard Gralla. Transatlantic Onologie Cancer Toxicity Management (CTM) Meeting 10th Annual, Paris France December 3, 2020
  531. Oral health for the head and neck cancer survivor.  Northern Colorado Head and Neck Cancer Support Group, Ed King, January 11, 2021
  532. Taste: A forgotten oral sensation. in 2021 Cedars-Sinai Advanced Otolaryngology Conference. Cedars Sinai Health System, Los Angeles CA March 13, 2021.
  533. COVID-19: What about history and what have we done: Part 2. Cosmo Spectrum Study Club. Vancouver BC, March 26, 2021.
  534. MOST Rapid Recovery from Covid. With Dr. R. Kramer; Kramer Consulting, Los Angeles, CA. March 30, 2021
  535. Your mouth and chronic oral graft versus host disease. BMT InfoNet Survivorship Program. April 19, 2021.
  536. GVHD Oral Care. Transplantation Disease Team, Dr. R. Nakamura. City of Hope National Medical Center, Duarte, CA. May 5, 2021.
  537. Your mouth and GVHD, in: Living your best life: Survivorship after Stem Cell Transplant. Susan Slater, Oregon Health Sciences University, Portland OR. June 8, 2021
  538. COVID-WTF. Medical-Dental Study Club. Vancouver Yacht Club, Vancouver, BC, November 18, 2021.
  539. Daily Drugs, Microbiota and Cancer Drugs. With Dr. D. Moro-Sibilot, Dr. L. De Rosa, Plenary Session, TAO Cancer Toxicity Management 11th Annual Meeting, Paris, France December 2, 2021.
  540. Patches, Sores and Bumps: Common Oral Lesions. Dr. A. Sadeghi and T. Barr, Port Coquitlam Study Club. Vancouver, BC February 16, 2022.
  541. Oral/Dental Needs in HNC Survivors. In: Patient-centric Head and Neck Care. Multidisciplinary Head and Neck Cancers Symposium, Extraordinary Care. Collaborative, Targeted, Divers, Patient Centered. Ameircan Head & Neck Cancer Society, ACSO, ASTRO, Society for Immunotherapy of Cancer. Phoenix, AZ February 24, 2022.
  542. Oral Complications of Immunotherapies and TKIs: Similarities and Differences to Conventional Oral Mucositis. J. Epstein, C. Estilo (Moderators) with Drs. N. Tsoukalas, B. Rapoport, S. Sonis. MASCC/ISOO Webinar March 3, 2022.
  543. COVID-19, 22-?? Los Angeles and District Dental Society, Los Angeles, CA. March 24, 2022
  544. TMJ and Orofacial Pain. Medical-Dental Study Club.  Vancouver, BC. May 12, 2022
  545. COVID-19 WTF. Alpha Omega Vancouver, BC. June 21, 2022
  546. Defining Common Methodologies for Patient Reported Symptom Monitoring; Immunecheckpoint Inhibitors, with Dr. B. Rappaport. MASCC/ISOO Annual Meeting, Toronto, Ont. June 23, 2022
  547. Patient Empowerment to Improve Mucositis Management. With Drs. N. Blejevns, P. Bossi, H. Wardell. MASCC/ISOO Annual Meeting, Toronto, Ont. June 25, 2022
  548. The dynamic role of dental medicine in head and neck cancer treatment and recovery. In: 2022 Survivorship after cancer of the head and Neck University of Pittsburgh Medical Center. Pittsburgh, PA August 1, 2022
  549. Mucositis: more than mouth sores. With Drs. P. Bonomo and Dr. B. Murphy. MASCC Webinar. November 3, 2022.
  550. Photobiomodulation and Taste. In 2022 Cancer Toxicity Management: Tolerance of Innovative Treatments. Transatlantic Organization (TAO), with F. Scotte, Paris France, Dec 15, 2022.
  551. The Role of Dental Medicine in Head and Neck Cancer Treatment and Survivorship. Cancer Survivoship Provider Network (CPSN) Education Meeting, Feb 17, 2023
  552. Oral Care of Cancer Patients: Survivorship. Oregon Dental Conference, Oregon Dental Association Portland Oregon. April 14, 2023.
  553. Taste and Saliva. Oregon Dental Conference, Oregon Dental Association. Portland Oregon. April 14, 2023
  554. Cancer Survivors in Your Office: Management of Oral Care Needs. Los Angeles and District Dental Society. Los Angeles, California May 23, 2023
  555. Oral Complications of Immunotherapies. Multinational Association for Supportive Care in Cancer/International Society of Oral Oncology/Japanese Association for Supproteive Care in Cancer Annual Meeting. Nara, Japan June 24, 2023
  556. Oral Complications of Cancer Immunotherapies. SOCAL Head and Neck Consortium. University of Southern California. Los Angeles, CA. July 29, 2023
  557. Oral Care in Cancer Survivors in 2nd Head and Neck Conference Ege University, Izmir, Turkey October 4, 2023.
  558. Dental Care and Oral Complications with Dr. A. Villa, Dr. S. Roser and J. Dagley. in Head and Neck Cancer Survivorship Symposium, Head and Neck Cancer Alliance, Indaianopolis, Indiana Oct 7, 2023.
  559. Common oral problems and their treatment, in Reducing Symptom Burden. UK Association of Supportive Care in Cancer. The Christie NHS Foundationi Trust, Manchester, UK, Oct 12, 2023.
  560. Photobiomodulation in oral oncology. UCSF Graduate Program in Oral Medicine, University of California, San Francisco. Oct 25, 2023.
  561. Photobiomodulation and Taste. in: Brazilian Society of Stpmatology (Oral Medicine) and Oral Pathology (SOBEP), Annual Meeting. Sao Paolo, Brazil Dec 2, 2023.
  562. Detection and Management of Oral Potentially Malignant Lesions. 91st Annual Midwinter Conference Meeting: Research Study Club of Los Angeles, Los Angeles CA, January 7, 2024
  563. Management of Oral Potentially Malignant Lesions. Division of Dentistry, Depart of Surgery, Cedars-Sinai Health System, Los Angeles, CA February 8, 2024.
  564. Understanding stomatitis, mouth sores and other oral side effects of chotherapy; Developing a plan to prevent and manage stomatitis and mouth sores. Chemotherapy: Novel approaches to prevent and manage gastrointestinal treatment side effects. With Dr. R. Gralla, R. Clark-Snow, Dr. L. Schwartzberg, Dr. C. Messner. In: CancerCare Connect Education Workshop Feb 16, 2024.
  565. Diagnosis and management of oral potentially malignant epithelial lesions. Advanced Treatment Planning Study Group. Dr. D. Galen, Beverly Hills, CA Feb 26, 2024.
  566. Phtobiomodulation therapy for oral complications of cancer therapy, with Drs. S. Elad, N. Treister, P. Arany. International Association for Dental, Oral and Cranifacial Research (IADR) General Session, New Oreleans, LA, Mar 16, 2024